Kela-code for severe mental illness

F5_KELAMENT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 112 1 out of 7 registries used, show all original rules.	19244
4. Check minimum number of events None	19244
5. Include endpoints None	19244
6. Filter based on genotype QC (FinnGen only)	19244

Control definitions (FinnGen only)

Control exclude: F5_UNSMENDIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	F5_KELAMENT
CONTROL_EXCLUDE	F5_UNSMENDIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	112
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Kela-code for severe mental illness based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	160458	84706	74180
Only index persons	128635	68752	59883
Unadjusted period prevalence (%)
Whole population	2.25	2.43	2.07
Only index persons	2.42	2.53	2.29
Median age at first event (years)
Whole population	40.26	43.20	36.76
Only index persons	37.95	40.70	34.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19244	10406	8838
Unadjusted period prevalence (%)	3.71	3.55	3.90
Median age at first event (years)	34.41	34.68	34.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18029: Matched controls
180246

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IGY02

SPAT

38.1

323.0

583

158

N05BA06

ATC

lorazepam; systemic, sublingual

21.0

323.0

3654

2150

N05AX08

ATC

risperidone; systemic

55.2

323.0

8648

2958

N03AX09

ATC

lamotrigine; oral

20.4

323.0

4015

2501

IGV01

NOMESCO Finland

Psychiatric network contact

43.2

323.0

680

163

AA400

NOMESCO Finland

Electroconvulsive therapy

48.6

323.0

862

186

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.9

323.0

891

1041

N05AX12

ATC

aripiprazole; systemic

135.4

323.0

6477

743

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

57.3

323.0

2613

532

A06AD11

ATC

lactulose; oral

3.6

323.0

3209

10280

T90

ICPC

Diabetes non-insulin dependent

2.4

323.0

4024

18960

P76

ICPC

Depressive disorder

4.4

323.0

2045

5071

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

388.8

323.0

1310

N05AE04

ATC

ziprasidone; systemic

390.1

323.0

968

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

8.5

323.0

2403

3216

SPAT1234

SPAT

Support of social functional capacity

7.3

323.0

1747

2622

SPAT1301

SPAT

No procedures

2.0

323.0

5750

33669

29530

ICD-8 Finland

Schizophrenia, Paranoid type

1330.5

323.0

390

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

1675.2

323.0

318

N07BB01

ATC

disulfiram; oral

7.3

323.0

2103

3206

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

4654.6

323.0

464

OAB43

SPAT

0.3

323.0

672

22239

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.8

323.0

1757

2831

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

846.7

323.0

964

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

49.6

323.0

521

108

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

168.8

323.0

364

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

1021.1

323.0

400

T36

ICD-10 Finland

Poisoning by systemic antibiotics

13.8

323.0

3083

2660

N05CD07

ATC

temazepam; oral

8.2

323.0

4979

7994

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

646.8

323.0

443

N03AG01

ATC

valproic acid; systemic, rectal

27.2

323.0

5675

2996

N05AA01

ATC

chlorpromazine; systemic, rectal

185.4

323.0

1879

113

N05AH02

ATC

clozapine; systemic

1500.5

323.0

3511

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

1282.0

323.0

377

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

76.8

323.0

1790

258

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2120.0

323.0

3479

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

8101.0

323.0

786

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

51.0

323.0

540

109

N05BE01

ATC

buspirone; oral

12.3

323.0

1609

1430

N05BA01

ATC

diazepam; systemic, rectal

6.7

323.0

5305

10517

F20.0

ICD-10 Finland

Paranoid schizophrenia

1586.8

323.0

1028

N05AD01

ATC

haloperidol; systemic

31.0

323.0

2567

958

SPAT1307

SPAT

Psychosocial counselling and guidance

4.1

323.0

2048

5424

N05AD03

ATC

melperone; systemic

17.9

323.0

744

433

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

32.1

323.0

817

266

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.9

323.0

2619

5061

P01

ICPC

Feeling anxious/nervous/tense

3.2

323.0

2888

10246

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

914.1

323.0

359

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

74.6

323.0

521

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

15.7

323.0

1548

1073

IGY02

NOMESCO Finland

Psychiatric monitoring contact

20.5

323.0

1613

861

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

91.2

323.0

1397

166

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

56.7

323.0

405

N06AX03

ATC

mianserin; oral

7.8

323.0

1932

2735

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

24.2

323.0

633

270

P72

ICPC

Schizophrenia

558.2

323.0

2923

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

4256.3

323.0

426

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

20.9

323.0

761

380

P98

ICPC

Psychosis NOS/other

188.0

323.0

928

N06AA09

ATC

amitriptyline; systemic

3.3

323.0

2208

7363

IEV99

NOMESCO Finland

Other psychiatric network intervention

60.3

323.0

407

P99

ICPC

Psychological disorders other

27.0

323.0

2597

1119

N06AB03

ATC

fluoxetine; oral

5.6

323.0

4617

10435

N05BA12

ATC

alprazolam; oral

3.8

323.0

2843

8385

C07AA05

ATC

propranolol; systemic

2.8

323.0

4635

19819

N05AN01

ATC

lithium; oral

105.9

323.0

3581

422

N05AF03

ATC

chlorprothixene; systemic

72.1

323.0

3536

608

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

19.0

323.0

1330

753

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

3693.3

323.0

372

N06AX12

ATC

bupropion; oral

4.7

323.0

2256

5297

N06AG02

ATC

moclobemide; oral

5.9

323.0

1476

2698

N06AA04

ATC

clomipramine; systemic

10.1

323.0

749

773

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

18.1

323.0

1108

649

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.7

323.0

2221

6603

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

21.4

323.0

559

269

29999

ICD-8 Finland

Unspecified psychosis

128.2

323.0

438

F20

ICD-10 Finland

Schizophrenia

4924.1

323.0

955

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

19.6

323.0

645

340

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

3807.7

323.0

383

N06AX05

ATC

trazodone; oral

7.1

323.0

968

1419

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

1465.9

323.0

1352

F39

ICD-10 Finland

Unspecified mood [affective] disorder

10.6

323.0

919

905

N05AF05

ATC

zuclopenthixol; systemic

555.5

323.0

1486

N03AF01

ATC

carbamazepine; oral, rectal

4.7

323.0

1419

3248

EBA00

NOMESCO Finland

Extraction of tooth

2.2

323.0

6830

38836

F29

ICD-10 Finland

Unspecified nonorganic psychosis

143.5

323.0

6269

667

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5065.2

323.0

503

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

25.6

323.0

1208

504

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

26.6

323.0

498

192

N03AE01

ATC

clonazepam; systemic

6.6

323.0

2248

3787

N05CF01

ATC

zopiclone; oral

3.4

323.0

7667

31825

N06AX16

ATC

venlafaxine; oral

5.3

323.0

5193

12791

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.4

323.0

1192

1354

F10.20

ICD-10 Finland

Alcohol dependence currently independent

12.0

323.0

1129

998

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

62.0

323.0

2399

445

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

19.8

323.0

989

528

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.5

323.0

3129

7954

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

97.9

323.0

374

N05BA02

ATC

chlordiazepoxide; systemic

7.5

323.0

887

1236

N06AA12

ATC

doxepin; systemic

5.7

323.0

1707

3221

N06AB06

ATC

sertraline; oral

6.7

323.0

4807

9280

SPAT1240

SPAT

Therapeutic discussion

4.8

323.0

4011

10203

N05AE03

ATC

sertindole; oral

1165.4

323.0

455

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3423.5

323.0

1003

F28

ICD-10 Finland

Other nonorganic psychotic disorders

191.3

323.0

448

29599

ICD-8 Finland

Schizophrenia, Unspecified type

571.7

323.0

610

F60.9

ICD-10 Finland

Personality disorder, unspecified

17.9

323.0

997

588

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

67.1

323.0

973

153

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

263.1

323.0

1135

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

125.3

323.0

1172

100

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

11.2

323.0

754

700

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

18.0

323.0

1811

1114

A28

ICPC

Limited function/disability NOS

2.8

323.0

2433

9527

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

16.8

323.0

1892

1249

29580

ICD-8 Finland

Schizophrenia, Other

300.9

323.0

551

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.9

323.0

1672

2053

F20.5

ICD-10 Finland

Residual schizophrenia

1507.1

323.0

713

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

923.5

323.0

451

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

2179.6

323.0

872

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

+∞

323.0

386

N04AA02

ATC

biperiden; systemic

148.5

323.0

2747

218

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

323.0

2278

7889

F20.10

ICD-10 Finland

Raise schizophrenia continuously

1165.0

323.0

565

F25

ICD-10 Finland

Schizoaffective disorders

3714.1

323.0

374

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

+∞

323.0

473

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.6

323.0

4954

11507

P28

ICPC

Limited function/disability (P)

33.9

323.0

679

208

F61.0

ICD-10 Finland

Mixed personality disorders

16.1

323.0

1227

811

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

323.0

1963

6715

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

59.5

323.0

447

P29

ICPC

Psychological sympt/compl other

9.8

323.0

3320

4046

SPAT1254

SPAT

Administration of medicine

2.8

323.0

3099

12320

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

1995.5

323.0

410

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

3216.5

323.0

326

F31

ICD-10 Finland

Bipolar affective disorder

57.6

323.0

1411

265

SPAT1243

SPAT

Psychiatric/psychological examination

7.4

323.0

1303

1879

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

27.7

323.0

470

174

F20.8

ICD-10 Finland

Other schizophrenia

591.6

323.0

519

IGY99

NOMESCO Finland

Other psychiatric treatment contact

17.9

323.0

1188

709

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

12.5

323.0

1310

1122

N05AB03

ATC

perphenazine; systemic, rectal

79.9

323.0

4712

795

N06AB08

ATC

fluvoxamine; oral

6.8

323.0

985

1512

A10BA02

ATC

metformin; oral

2.4

323.0

4917

24208

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

323.0

2171

7797

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

1982.3

323.0

990

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.7

323.0

2856

11597

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

8.2

323.0

3405

4988

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

88.1

323.0

480

F21

ICD-10 Finland

Schizotypal disorder

171.2

323.0

849

N05BA04

ATC

oxazepam; oral

5.9

323.0

8626

24201

N06AB10

ATC

escitalopram; oral

2.8

323.0

5130

22143

N05AA02

ATC

levomepromazine; systemic

50.3

323.0

4805

1292

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

1308.9

323.0

1879

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

92.9

323.0

2619

330

F20.9

ICD-10 Finland

Schizophrenia, unspecified

985.3

323.0

3696

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

323.0

18029

F22.0

ICD-10 Finland

Delusional disorder

78.1

323.0

1664

234

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

2082.1

323.0

1035

P73

ICPC

Affective psychosis

181.8

323.0

615

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

69.1

323.0

673

101

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

80.8

323.0

1849

254

N05AH04

ATC

quetiapine; oral

19.7

323.0

11223

13932

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

23.1

323.0

957

436

N05AL01

ATC

sulpiride; systemic

24.9

323.0

1083

461

F99

ICD-10 Finland

Mental disorder, not otherwise specified

76.7

323.0

1193

166

N06AB05

ATC

paroxetine; oral

5.2

323.0

2209

4730

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

23.9

323.0

1483

673

IEY01

NOMESCO Finland

Psychoeducation, individual

27.9

323.0

547

202

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2605.1

323.0

2388

F31.8

ICD-10 Finland

Other bipolar affective disorders

30.2

323.0

1796

657

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

21.7

323.0

709

339

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

14.3

323.0

2433

1942

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

323.0

3915

18539

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

393.8

323.0

350

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.2

323.0

3235

11427

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.3

323.0

4724

23713

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

1968.0

323.0

364

N05AX13

ATC

paliperidone; systemic

8264.7

323.0

801

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

40.1

323.0

688

178

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.9

323.0

2578

7386

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

2247.7

323.0

680

N05AF01

ATC

flupentixol; systemic

17.8

323.0

959

566

N05AC02

ATC

thioridazine; oral

54.6

323.0

2397

505

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

58.3

323.0

3443

728

N05AE05

ATC

lurasidone; oral

195.1

323.0

438

188

Kela drug reimbursment

Psychosis requiring demanding treatment

16384.0

323.0

1656

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

72.0

323.0

1887

292

N05AH03

ATC

olanzapine; systemic

114.4

323.0

9378

1689

N06AB04

ATC

citalopram; systemic

6.0

323.0

7799

20324

N06AX11

ATC

mirtazapine; oral

3.4

323.0

8043

34405

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

99.7

323.0

485

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.3

323.0

3690

8339

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

343.5

323.0

796

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.1

323.0

1993

4301

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

318.1

3964

20505

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

786.8

315.4

310

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.6

313.2

711

855

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

27.0

312.1

438

166

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

26.8

309.3

435

166

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

6.0

305.2

891

1542

N06AA06

ATC

trimipramine; systemic

6.4

304.9

844

1363

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

83.5

304.7

344

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

37.9

304.5

393

106

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

32.0

303.2

407

130

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

301.1

4412

24392

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.9

299.2

1359

3736

F34.1

ICD-10 Finland

Dysthymia

4.7

296.1

1088

2448

P74

ICPC

Anxiety disorder/anxiety state

4.4

295.8

1156

2767

IGP01

NOMESCO Finland

Psychiatric family contact

39.5

293.2

375

IER01

NOMESCO Finland

Psychoeducation, group

24.8

290.9

418

172

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

8.4

290.6

668

819

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

1447.7

288.9

281

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

103.4

286.1

315

P27

ICPC

Fear of mental disorder

10.7

285.5

572

549

P03

ICPC

Feeling depressed

2.7

283.0

2170

8674

P15

ICPC

Chronic alcohol abuse

5.3

282.7

918

1804

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

85.0

281.4

317

F30.9

ICD-10 Finland

Manic episode, unspecified

81.0

280.6

318

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

30.1

279.7

381

129

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

277.8

4058

22284

P50

ICPC

Psychological, Medication/prescr/renewal

37.6

273.9

354

30041

ICD-8 Finland

Neuroses, Depressiva

12.8

271.3

498

399

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

447.5

266.3

266

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.6

265.6

1298

3783

K02.1

ICD-10 Finland

Caries of dentine

1.7

265.2

10472

80199

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

2495.9

264.9

256

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

260.5

5518

34680

2971A

ICD-9 Finland

Paranoid states, Paranoia

139.6

257.3

275

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.1

256.6

603

765

K59.09

ICD-10 Finland

Constipation, unspecified

3.7

256.4

1205

3397

R53

ICD-10 Finland

Malaise and fatigue

2.1

256.1

3653

19771

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

10.1

256.0

528

535

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

+∞

253.7

243

SPAT1235

SPAT

Mental health, emotional support

15.5

251.2

424

279

P80

ICPC

Personality disorder

23.8

251.1

365

156

SPAT1241

SPAT

Extensive assessment of psychosocial situation

8.4

250.0

573

698

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

91.4

250.0

279

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

46.0

248.6

308

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

257.8

248.0

254

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.6

247.7

910

2040

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

5.7

244.1

748

1370

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.9

243.2

640

961

N05AB01

ATC

dixyrazine; systemic

10.2

242.1

498

502

M01AH05

ATC

etoricoxib; oral

0.6

240.1

5711

79870

ICB03

SPAT

115.1

239.8

261

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

47.5

239.6

295

F20.03

ICD-10 Finland

Paranoid schizophrenia periodically with gradual improvement

+∞

236.9

227

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

235.3

4376

26091

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.1

233.0

546

689

29540

ICD-8 Finland

Acute schizophrenia episode

301.0

232.2

236

T82

ICPC

Obesity

4.1

230.3

957

2415

AA1AD

NOMESCO Finland

CT of head and brain

2.0

229.8

3713

20987

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

229.6

220

F10.24

ICD-10 Finland

Alcohol depence active use

7.5

228.2

563

769

N05AH05

ATC

asenapine; oral

136.8

227.0

243

N05CD02

ATC

nitrazepam; oral

7.8

223.9

541

716

WX290

NOMESCO Finland

Other blockade of nerve

1.7

223.1

8313

61266

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

1086.5

220.1

215

SPAT1252

SPAT

Overall medication plan or its review

3.1

218.7

1291

4322

F20.6

ICD-10 Finland

Simple schizophrenia

547.0

218.6

217

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

2036.0

217.9

211

30188

ICD-8 Finland

Personality disorders, Alia definita

31.3

217.4

293

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

52.3

217.4

263

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

97.3

216.7

240

EBA30

NOMESCO Finland

Excision of root of tooth

3.3

216.1

1164

3644

F23.20

ICD-10 Finland

Acute schizophrenia-like psychosis without acute stress factor

432.7

215.0

215

IHZ07

SPAT

27.6

214.7

299

110

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

15.5

214.5

362

238

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

214.0

2262

10625

F61

ICD-10 Finland

Mixed and other personality disorders

19.4

214.0

332

174

N05AX15

ATC

cariprazine; oral

221.6

212.0

219

N05AC01

ATC

periciazine; systemic

26.0

212.0

300

117

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

19.6

211.3

327

170

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

210.1

8504

63702

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

8.2

209.1

487

608

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.4

208.5

993

22831

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

21.8

208.3

311

145

F40.1

ICD-10 Finland

Social phobias

4.7

208.3

755

1665

K59.0

ICD-10 Finland

Constipation

3.4

207.6

1108

3442

L17

ICPC

Foot/toe symptom/complaint

1.9

207.1

4050

24391

29500

ICD-8 Finland

Schizophrenia, Simple type

686.0

206.8

204

F60.8

ICD-10 Finland

Other specific personality disorders

13.4

206.5

371

283

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

206.4

9364

72151

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

76.6

205.1

234

SPAT1260

SPAT

Consultation of another employee

2.0

205.0

3074

16784

SPAT1244

SPAT

Occupational therapy

11.1

202.8

398

366

X78

ICD-10 Finland

Intentional self-harm by sharp object

15.0

202.3

346

235

F20.33

ICD-10 Finland

Undifferentiated schizophrenia periodically with gradual improvement

1883.3

202.2

196

F05.9

ICD-10 Finland

Delirium, unspecified

7.2

202.0

515

738

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

201.9

3532

20426

K08.3

ICD-10 Finland

Retained dental root

2.8

201.3

1380

5095

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

200.8

6693

47369

SPAT1310

SPAT

Counselling related to known health issue

1.7

200.0

5349

35532

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

199.9

12373

102990

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.9

196.2

674

1403

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

1822.3

196.0

190

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

88.3

194.6

218

N05CF02

ATC

zolpidem; oral

2.0

193.9

3118

17448

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

15.6

193.2

325

212

N06AX21

ATC

duloxetine; oral

2.3

192.5

2041

9569

H03AA01

ATC

levothyroxine sodium; systemic

1.8

192.3

3754

22508

R41.0

ICD-10 Finland

Disorientation, unspecified

5.1

192.2

644

1304

N05BA05

ATC

potassium clorazepate; oral

11.6

192.2

368

322

V03AA01

ATC

6.3

190.0

533

871

F23.29

ICD-10 Finland

Acute schizophrenia-like psychosis UNS

381.3

189.1

190

F60.0

ICD-10 Finland

Paranoid personality disorder

24.5

188.4

271

112

RS220

NOMESCO Finland

7.6

187.7

459

618

D12

ICPC

Constipation

4.4

187.5

719

1676

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

33.5

187.2

248

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

186.7

1212

4312

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

186.6

1406

5491

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

98.7

185.5

205

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.0

183.6

2801

15329

N06AX26

ATC

vortioxetine; oral

2.8

183.0

1294

4861

P19

ICPC

Drug abuse

8.0

182.3

431

551

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

18.9

180.9

283

152

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

179.1

801

2151

N06AX18

ATC

reboxetine; oral

8.3

178.6

411

503

C07AB07

ATC

bisoprolol; oral

1.6

178.1

6510

46775

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

49.2

175.1

214

30088

ICD-8 Finland

Neuroses, Other

24.3

174.8

252

105

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

5.4

174.5

549

1034

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

32.3

174.4

233

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.2

172.6

569

1131

IFA99

SPAT

133.5

172.5

185

S10

ICPC

Boil/carbuncle

2.9

171.6

1113

3954

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

14.4

171.2

297

209

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

5.0

170.9

577

1177

Z03

ICPC

Housing/neighbourhood problem

12.8

170.8

312

247

F30.0

ICD-10 Finland

Hypomania

39.4

170.8

218

-1

NOMESCO Finland

1.6

170.7

5952

42120

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3930

21263

2.07

319.78

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2956

14333

2.26

318.56

1.9

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

9784

71063

1.77

313.12

10.4

6.2

8.2

8.5

20.83

9146

66905

(42870588) Differential panel, method unspecified - Blood

7600

50059

1.86

307.65

7.5

6.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5366

28234

2.25

307.65

1.8

1.6

pmol/l

42860699.1

30029806.6

0.69

4580

23830

(3021960) Folate [Moles/volume] in Serum or Plasma

5595

29475

2.27

307.65

1.6

1.5

nmol/l

19.0

20.4

9.85

5073

25534

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9176

50108

2.59

307.65

4.0

3.2

u/l

31.5

33.4

0.53

8587

47634

(1001926) Buprenorphine [Presence] in Urine by Screen method

2413

6389

4.17

307.65

4.2

2.0

—

(40758558) Short blood count panel - Blood

6072

36882

1.94

307.65

13.5

6.4

—

(3026008) Bacteria identified in Urine by Culture

6296

39301

1.89

307.65

3.7

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5720

21846

3.30

307.65

2.7

1.7

1.6

1.4

73.47

5137

19517

(3013115) Eosinophils [#/volume] in Blood

11083

78039

1.99

307.65

12.7

5.8

e9/l

0.2

31.39

9867

69082

(3019309) Folate [Moles/volume] in Red Blood Cells

5290

22732

2.83

307.65

1.9

1.7

nmol/l

1221.4

1168.4

3.87

4180

17353

(3018418) pH of Serum or Plasma

6980

39697

2.19

307.65

3.6

4.2

7.4

0.17

1387

7656

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

10555

67424

2.25

307.65

6.4

6.7

mmol/l

1.2

17.78

8730

57046

(3028707) Methadone [Presence] in Urine by Screen method

2152

2988

7.98

307.65

4.5

2.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

12283

86607

2.16

307.65

23.4

8.2

e9/l

4.4

4.0

52.03

11044

75862

(3006315) Basophils [#/volume] in Blood

10794

75383

1.98

307.65

10.0

5.8

e9/l

0.0

10.28

9442

65775

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

2198

219

113.18

307.65

13.4

6.5

mmol/l

0.6

0.5

10.72

2037

198

(3011288) Drugs identified in Urine by Screen method

2256

5392

4.61

307.65

5.6

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

7293

43256

2.10

307.65

3.9

3.2

mmol/l

7.2

8.1

28.33

6168

36841

(3028300) Cannabinoids [Presence] in Urine

2580

8620

3.30

307.65

4.5

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8508

54705

2.00

307.65

2.2

1.9

pmol/l

95.8

97.0

1.54

4617

29094

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9716

60842

2.21

307.65

5.8

6.0

mmol/l

1.2

14.63

8911

55390

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7474

45416

2.06

307.65

2.9

2.6

u/l

51.4

58.0

22.40

6821

42097

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14946

113267

2.43

307.65

7.1

7.4

u/l

77.6

76.2

3.61

14196

106864

(3016879) Cocaine [Presence] in Urine

2539

7909

3.55

307.65

4.4

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15240

117571

2.42

307.65

5.6

3.8

pmol/l

14.6

14.7

6.20

14246

108012

(3044889) 12 lead EKG panel

13099

102082

1.89

307.65

4.5

3.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

11384

84581

1.85

307.65

5.6

4.6

mmol/l

6.8

6.6

5.30

10558

78465

(3024561) Albumin [Mass/volume] in Serum or Plasma

8834

60431

1.85

307.65

4.1

5.0

g/l

35.7

36.1

9.31

8128

56280

(3027008) Opiates [Presence] in Urine

2568

8604

3.29

307.65

4.4

1.8

—

(3027944) Amphetamines [Presence] in Urine

2475

8496

3.20

307.65

4.4

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

10932

77856

1.94

307.65

10.2

5.7

e9/l

2.0

1.9

12.11

9654

69236

(4198724)

860

654

13.72

307.65

3.0

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

7975

45771

2.27

307.65

2.7

3.4

mmol/l

2.4

0.58

7105

40349

(3019150) Specific gravity of Urine by Refractometry

5492

31715

2.02

307.65

5.2

3.7

kg/l

1.0

0.14

779

4561

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16648

140497

2.37

307.65

7.1

4.4

mu/l

1.9

2.1

3.23

15756

130349

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10291

74765

1.81

307.65

5.2

6.0

umol/l

9.0

11.2

91.02

9600

70873

(3009466) Valproate [Moles/volume] in Serum or Plasma

3252

1079

36.06

307.65

6.9

3.2

umol/l

386.8

352.4

10.46

2915

915

(3001604) Monocytes [#/volume] in Blood

10747

75102

1.98

307.65

9.8

5.8

e9/l

0.6

9.15

9413

65554

(3000764) Benzodiazepines [Presence] in Urine

2583

8535

3.34

307.65

4.4

1.9

—

(3022096) Basophils/100 leukocytes in Blood

9474

68462

1.76

306.05

9.8

6.0

0.6

0.7

73.91

8832

64116

(3006504) Eosinophils/100 leukocytes in Blood

9700

70678

1.75

303.29

9.7

5.9

2.4

2.9

90.98

9036

66157

(21494755) Public health laboratory ask at order entry panel

503

21609

0.21

302.88

1.2

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2899

14235

2.22

301.65

1.9

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6414

41585

1.81

299.15

2.7

2.1

u/l

365.1

204.3

9.19

6004

39138

(3023368) Bacteria identified in Blood by Culture

5759

36261

1.84

294.82

4.6

4.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1055

3122

3.52

293.84

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1684

6546

2.72

292.25

2.1

1.6

mu/l

605.2

274.9

32.53

1458

5931

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8510

60268

1.74

289.90

2.5

2.2

nmol/l

70.4

1562.6

0.50

7874

55148

(3019550) Sodium [Moles/volume] in Serum or Plasma

17611

155844

2.53

286.19

20.7

13.8

mmol/l

139.5

139.7

12.64

17298

151820

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

517

897

5.90

283.21

2.8

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

414

577

7.31

280.27

2.9

1.7

umol/l

154.1

132.9

0.51

192

287

(3002030) Lymphocytes/100 leukocytes in Blood

9896

73644

1.71

276.72

10.0

5.9

28.4

28.6

0.91

9215

69029

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16822

146526

2.18

275.49

6.2

4.0

mmol/l

6.2

5.8

148.28

15824

135504

(3018010) Neutrophils/100 leukocytes in Blood

9769

72595

1.70

273.30

9.8

5.7

57.6

56.8

8.93

9085

68301

(3023103) Potassium [Moles/volume] in Serum or Plasma

17609

156439

2.48

272.46

20.6

13.9

mmol/l

4.0

4.58

17275

152071

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13558

110330

1.77

270.96

4.9

2.9

u/l

47.4

45.5

2.04

12766

104301

(3042517) Benzodiazepines panel - Urine

237

186

12.89

245.74

2.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

12009

96402

1.65

231.87

5.6

4.1

e6/l

1618.3

1489.1

0.10

273

1251

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

506

18414

0.26

226.18

1.6

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

5938

40492

1.67

215.19

4.0

4.1

mg/mmol

8.3

9.5

0.73

3654

26135

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1748

7958

2.32

213.94

7.6

7.2

mmol/l

25.4

24.5

14.45

1641

7405

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15820

137951

1.82

213.11

7.2

5.1

mmol/mol

39.6

39.1

9.12

14845

129126

(3021589) Normoblasts [#/volume] in Blood

8838

66716

1.60

211.23

13.0

8.9

e9/l

0.0

0.64

7261

54875

(3020191) Ethanol [Moles/volume] in Serum or Plasma

551

1303

4.32

210.17

1.7

1.4

promille

0.9

1.5

15.07

401

987

(3029937) Albumin [Presence] in Urine by Test strip

5708

39021

1.66

202.20

4.8

3.8

estimate

0.0

5.86

1821

13602

(3012516) Albumin [Mass/volume] in Urine

5643

38597

1.65

198.79

3.2

3.3

mg/l

395.7

424.7

0.17

3475

24765

(3003396) Base excess in Arterial blood by calculation

2677

14816

1.94

194.76

6.9

7.7

mmol/l

1.9

0.9

26.79

2101

11602

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3846

23835

1.77

194.45

2.6

3.0

mmol/l

2.4

0.80

3300

20825

(3002032) Base excess in Venous blood by calculation

2263

11832

2.03

193.82

3.7

4.1

mmol/l

2.3

1.8

5.18

1820

9673

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2265

11888

2.03

191.81

3.6

4.1

kpa

6.0

5.8

6.99

2173

11528

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1680

7909

2.23

188.84

1.7

1.5

—

(3019060) Gas panel - Arterial blood

1733

8282

2.20

187.66

5.3

5.0

—

(3016502) Oxygen saturation in Arterial blood

2426

13164

1.96

186.50

7.0

8.2

94.8

95.9

15.85

2341

12670

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5070

34441

1.64

180.06

2.3

2.2

mg/l

2.9

0.22

4378

29584

(3012544) pH of Venous blood

2289

12321

1.97

179.70

3.5

4.1

7.4

0.86

(3027801) Oxygen [Partial pressure] in Arterial blood

2629

14830

1.90

179.41

6.9

7.7

kpa

11.0

12.8

64.78

2499

14157

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2629

14837

1.89

179.13

6.9

7.7

kpa

5.3

5.1

24.12

2495

14174

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5438

37751

1.61

176.10

1.8

1.6

mmol/l

1.7

1.4

71.27

4664

32203

(3024354) Oxygen [Partial pressure] in Venous blood

1891

9602

2.08

174.43

3.3

kpa

4.8

4.7

2.32

1803

9270

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2243

12247

1.94

168.17

7.3

8.6

g/l

124.2

122.7

2.68

2155

11802

(3026782) Osmolality of Urine

4121

27006

1.67

166.42

2.9

2.7

mosm/kgh2o

492.9

552.3

48.45

3491

23068

(3023511) Choriogonadotropin [Units/volume] in Urine

920

3532

2.69

161.28

1.7

1.3

—

(3017509) Phencyclidine [Presence] in Urine

182

184

9.98

159.53

3.3

1.2

—

(3008295) Osmolality of Serum or Plasma

469

1234

3.87

154.56

1.6

1.5

mosm/kgh2o

285.0

279.6

3.83

346

983

(3023183) Ammonium ion [Moles/volume] in Plasma

768

2766

2.85

152.07

2.1

3.0

umol/l

32.6

34.4

0.69

662

2378

(1761868) Lipid panel - Serum or Plasma

4388

61604

0.63

151.62

3.4

2.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2886

17575

1.76

150.98

4.4

6.4

mmol/l

1.0

0.55

2648

16483

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

642

2100

3.13

150.87

2.0

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

12193

103063

1.50

148.64

5.0

4.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

352

12414

0.27

144.52

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

404

1031

3.98

138.94

2.0

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6877

52343

1.49

138.78

4.1

3.2

ng/l

39.3

63.9

1.23

4665

31908

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3426

22340

1.65

137.71

2.6

3.5

mmol/l

0.8

6.53

3118

20942

(40760892) CBC W Ordered Manual Differential panel - Blood

4952

35447

1.53

132.94

8.0

4.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2057

11732

1.84

132.90

5.8

7.5

mmol/l

1.4

1.3

3.78

1950

11318

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

953

20239

0.44

131.94

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1940

10911

1.87

130.95

3.6

3.8

mmol/l

1.2

3.09

1679

9583

(3035350) Ketones [Presence] in Urine by Test strip

9096

73791

1.44

128.32

4.5

3.3

estimate

0.0

0.02

1815

13693

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

279

576

4.90

125.85

1.5

1.4

mu/l

807.9

479.0

2.79

257

549

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

282

591

4.83

124.96

1.5

1.4

74.6

72.0

2.44

260

564

(3004119) Hemoglobin [Mass/volume] in Venous blood

1481

7740

1.99

124.35

3.2

3.5

g/l

130.5

130.7

0.17

1444

7563

(3018405) Lactate [Moles/volume] in Arterial blood

996

4467

2.30

124.34

4.5

4.2

mmol/l

1.4

0.65

979

4401

(3020891) Body temperature

1095

5125

2.21

123.28

5.7

4.9

—

(3000850) Epithelial cells [#/volume] in Urine

4177

29308

1.54

121.00

2.7

2.6

e6/l

7.7

5.6

13.20

3671

25612

(3011397) Hemoglobin [Presence] in Urine by Test strip

4682

33710

1.51

120.11

4.3

3.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1213

6002

2.09

118.26

3.5

mmol/l

25.6

25.2

3.94

1174

5810

(3009261) Glucose [Presence] in Urine by Test strip

9116

74689

1.42

117.74

4.5

3.4

estimate

0.0

0.17

1823

13638

(3014576) Chloride [Moles/volume] in Serum or Plasma

2646

16748

1.67

117.59

6.6

7.5

mmol/l

103.8

104.5

9.06

2538

16413

(3002582) Erythrocytes [#/volume] in Urine

5671

42617

1.47

117.08

3.4

3.1

e6/l

66.6

79.9

0.38

4446

32417

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

310

752

4.17

114.22

2.0

1.6

iu/ml

2782339.2

2028092.9

0.43

(3021601) Nitrite [Presence] in Urine by Test strip

9019

74037

1.41

113.64

5.7

4.6

estimate

0.0

0.18

1884

14093

(3015235) Bicarbonate [Moles/volume] in Capillary blood

771

3216

2.46

113.29

3.5

2.8

mmol/l

25.5

24.6

7.18

706

2792

(3017181) Myelocytes/100 leukocytes in Blood

2042

12186

1.76

112.23

6.1

4.1

0.9

0.28

614

3253

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1170

5848

2.07

110.84

3.0

3.1

0.7

0.15

1101

5630

(3001019) Free T4 and TSH panel - Serum or Plasma

301

10049

0.29

110.58

1.5

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1379

7342

1.95

109.23

1.8

1.6

—

(3018095) Leukocytes [#/volume] in Urine

6516

50755

1.43

109.22

3.9

3.5

e6/l

110.5

81.6

1.10

4757

35229

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1121

5554

2.08

108.69

4.3

3.9

53.9

49.1

8.00

1106

5493

(3043409) Potassium [Moles/volume] in Arterial blood

866

3878

2.29

108.27

4.7

4.4

mmol/l

3.8

3.9

0.43

792

3659

(3003181) Sodium [Moles/volume] in Urine

549

2005

2.79

105.63

1.4

mmol/l

53.9

64.6

7.36

398

1577

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2218

13879

1.68

101.90

1.9

2.2

nmol/l

387.2

370.3

2.46

2021

12787

(3030467) Casts [#/volume] in Urine by Automated count

5140

38915

1.44

98.36

3.2

3.0

e6/l

0.4

1.00

3956

28914

(1616796) Gas panel - Central venous blood

701

2993

2.39

97.70

3.9

3.4

—

(3000991) Gas panel - Venous blood

1842

11151

1.72

95.35

6.8

9.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

652

2747

2.42

93.57

3.0

2.7

kpa

8.2

8.3

0.75

624

2537

(3047181) Lactate [Moles/volume] in Blood

880

4207

2.14

93.46

6.6

5.9

mmol/l

1.4

1.3

1.12

777

3700

(3013707) Erythrocyte sedimentation rate by Westergren method

12633

111618

1.38

92.92

3.8

3.9

mm/h

11.8

10.8

11.95

11625

104159

(3021901) Oxygen saturation in Capillary blood

575

2296

2.55

92.59

2.9

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1637

9676

1.76

92.12

2.4

3.4

pmol/l

4.4

4.5

11.59

1353

8687

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

145

217

6.73

91.95

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1436

8181

1.82

91.56

3.5

3.2

kpa

5.3

5.1

11.38

1356

7552

(3002179) Metamyelocytes/100 leukocytes in Blood

1826

11154

1.70

91.26

5.4

3.9

0.6

0.33

373

2422

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7159

57929

1.38

91.24

4.9

3.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1377

7771

1.83

90.52

3.4

3.2

mmol/l

2.2

1.6

7.77

1055

5675

(3009343) pH of Capillary blood

1409

8072

1.80

88.08

3.5

3.2

7.4

0.12

254

1034

(3010421) pH of Blood

772

3615

2.18

86.34

4.6

3.7

7.4

5.21

628

3071

(36304419) Bacteria [Presence] in Urine

4982

38365

1.40

83.97

3.2

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

1859

11659

1.66

83.69

6.5

4.1

0.1

0.51

530

3037

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1306

7438

1.81

83.10

2.7

2.4

u/l

4613.6

5942.9

0.72

332

3006

(3007853) Bacteria identified in Skin by Aerobe culture

2560

17426

1.54

81.43

1.8

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1137

6298

1.86

79.07

3.7

4.4

mmol/l

24.4

24.2

1.75

947

5691

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

17.16

78.96

1.5

1.4

nmol/l

435.9

587.8

0.63

(40761535) Cells panel - Urine sediment

1758

11099

1.64

76.77

3.6

3.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2132

14105

1.58

76.65

3.0

2.5

1.8

0.73

1848

12555

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2478

16960

1.53

76.48

8.3

6.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

399

1461

2.77

76.37

13.3

9.8

mmol/l

7.5

0.03

336

1209

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

976

5225

1.91

75.38

5.8

5.2

2.0

1.7

7.91

907

4888

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

901

4723

1.95

74.07

2.3

2.4

ug/l

687.2

552.8

0.55

829

4397

(43055514) Macroprolactin [Presence] in Serum or Plasma

193

457

4.26

73.53

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1741

11090

1.63

73.19

6.7

4.1

0.0

0.2

2.08

401

2609

(3007930) Methemoglobin/Hemoglobin.total in Blood

958

5147

1.91

73.15

6.0

5.2

0.9

0.73

891

4817

(3002385) Erythrocyte distribution width [Ratio]

14451

132331

1.37

72.86

29.0

14.6

13.7

13.6

26.65

14161

129606

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16626

156095

1.48

71.84

5.6

4.3

mmol/l

2.7

2.8

88.15

15510

145850

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2089

13949

1.56

71.82

4.6

3.1

—

(40767503) Oxygen content in Capillary blood by calculation

616

2838

2.21

71.65

3.1

2.4

16.7

0.06

347

1407

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4489

34730

1.38

71.43

2.7

2.9

ng/l

1005.7

1257.3

4.49

3682

29233

(3032080) INR in Blood by Coagulation assay

6682

54984

1.33

70.89

7.6

7.9

inr

1.1

1.2

17.15

2384

16199

(3020779) Urea [Moles/volume] in Serum or Plasma

1820

11837

1.59

70.04

5.0

8.2

mmol/l

8.4

9.3

6.91

1721

11308

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1368

8281

1.70

69.94

8.0

9.7

1.8

1.4

18.74

1361

8229

(3006184) Hemoglobin [Mass/volume] in Capillary blood

637

3011

2.15

69.46

2.5

2.1

g/l

131.8

131.6

0.08

554

2132

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1358

8281

1.69

67.48

8.0

9.8

0.7

0.32

1352

8231

(3012501) Base excess in Blood by calculation

650

3135

2.11

67.27

4.7

3.7

mmol/l

2.9

2.4

3.36

458

2097

(3013290) Carbon dioxide [Partial pressure] in Blood

650

3137

2.11

67.16

4.7

3.8

kpa

5.2

5.0

9.35

628

3068

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17576

167351

1.58

66.93

12.5

9.5

u/l

28.5

27.7

3.90

17127

162149

(3027315) Oxygen [Partial pressure] in Blood

652

3160

2.10

66.61

4.7

3.8

kpa

8.7

8.8

0.89

630

3090

(3028271) Lactate [Moles/volume] in Capillary blood

490

2123

2.34

65.97

2.4

1.8

mmol/l

1.7

0.06

479

2076

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

462

9907

0.45

62.75

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

2433

17307

1.46

61.06

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1336

8321

1.65

61.01

8.2

9.9

92.6

94.1

16.17

1328

8297

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16353

154015

1.41

60.36

5.1

4.0

mmol/l

4.5

4.7

152.84

15304

144846

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3033

22543

1.41

59.79

2.3

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1186

7199

1.69

59.76

8.9

10.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

883

4932

1.83

59.49

2.1

2.0

ug/l

2.3

2.1

0.24

788

4365

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2361

16784

1.46

59.32

2.3

2.8

umol/l

6.2

8.2

7.74

1804

14598

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1999

13768

1.50

58.82

2.6

u/l

31.2

45.0

2.53

1683

11884

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3471

26506

1.38

58.03

4.0

3.5

ng/l

235.1

525.7

5.02

2313

19084

(3039000) Anion gap in Blood

594

2929

2.06

57.93

7.6

7.0

mmol/l

10.8

11.3

2.88

539

2624

(3018572) Chloride [Moles/volume] in Blood

594

2930

2.06

57.87

7.6

7.0

mmol/l

105.1

0.07

539

2625

(3017143) Hepatitis C virus Ab [Presence] in Serum

2922

21693

1.41

57.78

1.8

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1544

10099

1.57

57.49

1.6

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

125

6.99

57.38

1.2

1.3

mg/l

50.8

47.8

0.15

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15757

147856

1.36

56.38

4.5

3.6

mmol/l

1.6

1.3

227.57

14562

137964

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16589

157180

1.40

54.15

17.6

12.5

mg/l

22.9

22.7

0.43

13862

122475

(3013512) EKG study

4791

38777

1.31

53.57

4.3

3.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

385

3.97

53.01

3.5

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

385

3.97

53.01

3.5

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1766

25137

0.67

52.91

2.5

2.7

ug/l

0.6

0.7

11.44

1232

14814

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16188

153063

1.36

50.97

5.0

3.9

mmol/l

1.3

1.4

307.65

15071

143443

(40768804) Tissue Pathology biopsy report

5088

61017

0.77

50.31

1.9

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

548

2772

2.01

49.80

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

636

3389

1.91

49.64

1.2

1.4

e6/l

46.9

29.2

0.34

472

2610

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1463

9763

1.54

49.55

3.2

4.1

ng/l

84.0

91.9

2.21

1226

8528

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

634

3392

1.90

48.87

1.2

1.4

e6/l

657.0

2501.0

0.97

510

2753

(3019977) pH of Arterial blood

208

682

3.07

48.78

3.4

2.5

7.4

1.21

222

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1842

12937

1.47

48.66

2.2

2.3

g/l

0.2

0.99

1658

12057

(3007463) Buprenorphine [Presence] in Urine

8.40

47.94

5.5

8.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3207

24862

1.35

47.53

2.4

2.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

626

3386

1.88

46.65

1.2

mmol/l

4.0

3.7

3.23

586

3188

(3050129) First trimester maternal screen panel - Serum or Plasma

285

6563

0.43

46.30

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

3327

0.20

46.26

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

1808

12777

1.46

46.13

4.4

3.7

—

(3042936) Bacteria identified in Isolate by Culture

2684

20345

1.37

45.81

2.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

689

3862

1.81

45.80

1.2

1.3

mg/l

485.3

517.3

0.84

651

3687

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

166

497

3.36

45.27

3.0

2.9

umol/l

28.2

28.5

0.07

110

380

(3022806) Fractional oxyhemoglobin in Capillary blood

378

1743

2.19

43.93

2.4

1.7

89.9

90.2

0.39

372

1714

(3021367) Citalopram [Moles/volume] in Serum or Plasma

15.44

42.52

1.7

1.3

nmol/l

142.3

128.7

0.16

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

205

5219

0.39

42.36

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3042

23757

1.33

42.36

2.8

2.7

e6/l

1.5

1.2

1.18

1718

13297

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

208

5234

0.39

41.84

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

208

5230

0.39

41.76

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

1497

10391

1.48

41.71

2.1

2.7

e9/l

73.8

70.7

2.35

1134

7793

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

233

5575

0.41

41.58

1.4

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2837

21985

1.34

41.57

2.2

2.5

umol/l

12.5

13.7

12.66

2574

20458

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

207

5197

0.39

41.41

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10568

115269

0.82

40.31

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1541

10937

1.44

38.12

2.5

2.3

ug/l

5.6

7.8

4.35

1323

9573

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2606

20259

1.33

36.97

2.2

2.5

g/l

2.4

3.50

2313

18832

(3044242) Glucose [Moles/volume] in Arterial blood

167

570

2.95

36.63

2.3

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1206

8223

1.50

36.59

6.2

7.4

mmol/l

25.4

24.7

7.73

1184

8156

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

782

4842

1.64

36.25

2.0

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

199

763

2.62

35.03

1.0

ng/l

45.4

41.0

0.17

142

538

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

625

3685

1.72

34.89

1.3

—

(3005033) Fetal Nuchal fold Thickness US

162

4196

0.38

34.81

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

198

760

2.62

34.78

1.0

ng/l

760.6

755.5

0.05

142

526

(3043238) Trisomy 21 risk [Likelihood] in Fetus

170

4308

0.39

34.75

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

163

4205

0.38

34.71

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

557

3184

1.77

34.68

1.2

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

1377

2.18

34.54

1.2

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1549

11198

1.42

34.50

1.2

iu/ml

82.9

148.1

13.11

506

4319

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

197

759

2.61

34.35

1.0

ng/l

236.0

319.4

4.87

145

548

(4034850)

756

4706

1.63

34.30

13.2

8.6

—

(3036180) Methadone [Presence] in Urine

10.59

33.95

3.2

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

102

3245

0.31

33.66

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

103

3241

0.31

33.28

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15354

146041

1.25

32.98

15.4

11.3

ml/min/173m2

88.6

86.3

27.77

12055

120522

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4276

35865

1.25

32.87

1.3

u/ml

1.6

1.7

0.05

1151

10133

(3003694) ABO and Rh group [Type] in Blood

3866

46053

0.80

32.25

1.4

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2781

22226

1.29

31.82

3.0

2.8

e6/l

4.4

2.7

9.31

1469

11823

(3000492) Spirometry study

1186

16635

0.69

31.44

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4011

33565

1.25

31.22

1.8

mg/l

1.1

0.33

3003

25090

(3016038) Potassium [Moles/volume] in Urine

192

771

2.51

30.79

1.2

mmol/l

27.1

35.9

7.15

161

658

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

484

2751

1.78

30.76

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

145

509

2.86

30.31

1.4

1.5

pmol/l

13.0

15.1

4.28

117

423

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

494

2848

1.75

29.90

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

494

2849

1.75

29.87

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1464

10742

1.39

29.76

8.1

2.4

e9/l

4.3

4.1

1.45

1178

8639

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

287

1387

2.09

29.70

1.2

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1052

7275

1.47

29.65

2.9

2.6

e6/l

0.3

0.73

1029

7068

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7596

67983

1.19

29.55

2.9

2.8

ug/l

108.3

119.7

2.88

6953

63748

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

917

6213

1.50

28.61

1.1

u/ml

1.3

9.1

1.04

(4035726)

833

12238

0.67

28.11

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

666

4246

1.59

27.40

2.8

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2119

16682

1.30

26.83

17.0

21.5

inr

1.2

1.3

2.12

279

2513

(3024928) Oxygen saturation in Venous blood

480

2835

1.71

26.69

2.2

3.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

391

2189

1.80

26.21

2.7

3.3

1.3

1.4

0.38

282

1715

(3000034) Microalbumin [Mass/volume] in Urine

249

1229

2.04

24.44

3.3

2.9

mg/l

28.1

58.9

2.03

181

883

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

528

3287

1.62

24.01

1.4

1.7

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

114

4.75

23.99

1.3

1.4

pmol/l

23.3

14.5

0.87

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

360

2022

1.80

23.91

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1418

10726

1.35

23.67

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

249

4724

0.52

23.31

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

509

3172

1.62

23.06

1.4

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4222

36458

1.20

23.00

2.2

2.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

164

706

2.33

22.71

1.8

2.3

umol/l

11.1

29.1

1.73

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2318

18824

1.26

22.70

2.3

2.6

20.9

23.5

15.53

1836

16195

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

176

784

2.26

22.50

1.2

1.3

77.1

64.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

142

578

2.47

22.27

2.5

3.4

—

(3022621) pH of Urine by Test strip

1233

9214

1.36

22.25

3.9

2.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

155

4.01

22.25

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1367

10378

1.34

22.24

2.8

ng/l

126.8

180.5

6.95

1204

9327

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

229

4375

0.52

21.94

1.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

496

3114

1.61

21.82

3.9

3.4

e9/l

4.4

4.0

3.14

496

3108

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

155

665

2.34

21.65

2.8

2.3

umol/l

52.4

52.3

0.01

126

558

(4010399)

1359

10350

1.34

21.63

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

966

6983

1.40

21.34

8.6

10.1

mmol/l

24.8

24.2

4.76

854

6559

(3009542) Hematocrit [Volume Fraction] of Blood

14373

149597

0.85

21.28

26.8

12.8

39.5

40.6

25.83

8674

116615

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

398

2386

1.68

21.03

1.3

1.5

—

(3022313) Gas panel - Capillary blood

830

5858

1.44

20.99

3.7

3.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

8.45

20.98

1.9

1.5

nmol/l

256.4

348.7

0.27

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

199

969

2.06

20.36

1.2

1.1

—

(3045716) Anion gap in Serum or Plasma

136

576

2.37

19.61

2.3

2.5

mmol/l

8.6

9.3

1.02

426

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

46.03

19.16

3.6

1.2

nmol/l

70.4

68.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

247

1325

1.88

19.13

1.3

1.4

nmol/l

1.7

1.4

2.26

224

1189

(3017569) Oxygen content in Arterial blood

128

534

2.41

19.11

2.6

2.0

—

(4094501)

215

4004

0.53

19.01

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

828

5970

1.40

18.58

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

189

3627

0.52

18.43

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

364

2209

1.66

18.41

1.6

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

114

468

2.44

17.67

4.9

6.6

mmol/l

26.2

25.0

2.09

108

428

(3002256) Pathology report gross observation

1523

18981

0.79

17.49

1.2

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2521

21262

1.21

17.02

1.8

2.2

29.5

29.7

1.12

2428

20631

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

295

1731

1.72

16.97

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

597

4129

1.46

16.87

1.4

ug/g

291.3

277.1

0.95

347

2334

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

222

1200

1.86

16.86

1.2

1.3

mmol/l

2.1

2.0

0.23

204

1123

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

240

1332

1.81

16.74

1.4

2.0

nmol/l

18.6

19.2

0.49

217

1256

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

296

4873

0.60

16.70

1.3

—

(44790048)

272

1568

1.75

16.68

1.3

1.6

—

(44790047)

272

1568

1.75

16.68

1.3

1.6

—

(44806118)

272

1568

1.75

16.68

1.3

1.6

—

(44790049)

272

1568

1.75

16.68

1.3

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6500

70891

0.87

16.35

4.2

3.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

160

784

2.05

16.20

1.2

1.3

u/l

272.7

356.6

0.50

147

720

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.76

16.11

1.1

1.2

mmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

488

3273

1.50

16.10

2.0

2.5

ug/min

97.4

125.3

0.68

263

2048

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

917

6881

1.35

16.10

2.3

2.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.43

16.08

1.5

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1670

13570

1.25

16.01

2.2

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3423

39022

0.85

15.68

2.3

2.5

umol/l

3040.5

3595.2

0.43

2838

34448

(3008116) Ketones [Moles/volume] in Urine by Test strip

310

2.68

15.67

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

440

2917

1.52

15.36

1.6

2.4

nmol/l

1.0

0.8

3.19

353

2475

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

414

2709

1.54

15.35

1.5

1.3

u/l

20.5

24.8

2.20

320

2236

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2143

25366

0.83

15.03

1.3

u/ml

9.5

11.0

0.35

701

10370

(3009214) Lutropin [Units/volume] in Serum or Plasma

765

5650

1.37

14.89

1.3

1.4

u/l

8.9

8.8

0.01

600

4656

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1115

8705

1.30

14.81

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

119

539

2.22

14.80

2.9

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

116

2414

0.48

14.54

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

358

2308

1.56

14.23

1.6

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

297

1840

1.62

13.97

1.4

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

627

4537

1.39

13.85

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3123

35531

0.86

13.67

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

628

4571

1.39

13.41

1.2

—

(36660697) Celiac disease serology panel - Serum

1550

12734

1.24

13.41

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

229

1345

1.71

13.25

2.6

3.3

61.5

57.7

1.62

106

897

(3048689) Calprotectin [Mass/mass] in Stool

2412

20711

1.19

13.19

2.0

2.5

ug/g

130.4

136.5

0.34

1802

16484

(3014271) Vancomycin [Susceptibility]

115

541

2.13

13.07

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

627

4589

1.38

12.96

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2131

18134

1.20

12.89

1.6

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1170

0.31

12.69

1.2

1.3

g/l

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

16853

164840

1.18

12.41

19.6

11.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

899

0.22

12.38

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1204

0.33

12.16

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

112

2205

0.51

12.00

1.0

1.1

u/ml

0.2

0.6

1.11

480

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

455

2.18

11.98

1.1

—

(1002224) Polysomnography panel

576

7771

0.73

11.85

1.1

—

(40768800) Prostate Pathology biopsy report

122

2321

0.52

11.75

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

180

1026

1.76

11.65

1.5

—

(3023410) Appearance of Cerebral spinal fluid

254

1588

1.61

11.61

1.3

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

263

2.55

11.58

1.3

1.2

mg/l

0.7

65.2

1.25

186

(3041096) Erythrocytes [Presence] in Urine by Automated

4612

41909

1.13

11.53

4.1

3.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

204

3341

0.61

11.40

1.1

u/ml

2.7

6.0

7.15

109

1765

(3019225) pH of Specimen

1568

13113

1.21

11.37

4.1

4.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

455

3228

1.42

11.35

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

148

2628

0.56

11.29

1.0

1.1

u/ml

2.7

3.1

0.18

1385

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

834

1.83

11.19

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

678

5143

1.33

11.15

3.8

3.4

mmol/l

25.0

24.8

0.82

641

4747

(3014133) Dog dander IgE Ab [Units/volume] in Serum

156

2715

0.57

11.07

1.1

u/ml

2.1

4.4

2.93

1080

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.61

11.02

1.1

u/l

10.0

11.5

0.18

(3008898) HLA-B27 [Presence]

456

6301

0.72

10.94

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

808

0.23

10.83

2.7

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

807

0.23

10.80

5.4

6.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

140

2486

0.56

10.71

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

300

4450

0.67

10.69

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

343

2335

1.48

10.68

1.4

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

250

2.52

10.68

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

192

3136

0.61

10.65

1.1

u/ml

0.7

2.2

3.10

790

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

554

4121

1.35

10.42

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

174

2895

0.60

10.41

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

265

1721

1.55

10.34

1.1

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

241

3703

0.65

10.22

1.1

u/ml

2.2

1.4

0.33

111

1500

(3008401) Mugwort IgE Ab [Units/volume] in Serum

198

3170

0.62

10.11

1.1

u/ml

0.9

1.2

0.53

1362

(3047007) Chlamydophila sp Ab [Presence] in Serum

144

2496

0.57

10.11

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

566

4246

1.34

10.08

2.6

—

(3025941) Bacteria identified in Stool by Culture

1152

9453

1.23

10.08

1.3

1.2

—

(44806420)

294

2.35

10.06

2.5

2.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2372

26975

0.86

9.99

1.3

iu/ml

29.5

33.6

0.66

609

8377

(3023419) Bacteria identified in Sputum by Culture

243

1571

1.55

9.71

1.9

2.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

2525

0.59

9.63

1.1

u/ml

5.5

4.6

0.21

1056

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

438

0.18

9.54

1.3

1.1

u/ml

31.3

56.9

—

426

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

2479

0.59

9.51

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

385

5338

0.72

9.48

1.7

1.6

iu/ml

4.1

6.1

0.16

1117

(1761482) Bacteria [#/volume] in Urine by Culture

431

3131

1.39

9.44

5.4

3.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1768

0.52

9.26

1.3

pmol/l

59.7

142.5

0.87

507

(3007566) Smooth muscle Ab [Titer] in Serum

592

4531

1.32

9.21

1.2

1.3

titre

104.8

117.2

0.18

423

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1349

0.46

9.01

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

226

1464

1.55

8.99

2.8

2.2

mmol/l

104.8

105.7

1.93

226

1451

(3044640) Blood type and Crossmatch panel - Blood

4298

46782

0.90

8.97

2.4

2.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

3.64

8.96

1.6

1.3

mmol/l

25.9

22.1

1.89

(3041354) Potassium [Moles/volume] in Venous blood

226

1465

1.55

8.96

2.8

2.2

mmol/l

4.1

4.0

0.37

226

1452

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

156

923

1.70

8.96

1.2

1.3

umol/l

5.4

5.3

0.12

145

857

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

489

1.97

8.96

1.1

1.2

7.7

20.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

278

1885

1.48

8.92

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

129

725

1.78

8.88

1.5

1.6

nmol/l

42.7

7.4

0.42

109

587

(3015183) Erythrocyte sedimentation rate

955

0.37

8.81

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

4120

37700

1.12

8.79

4.0

3.9

93.8

92.0

5.17

3948

36724

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

808

1.73

8.54

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

176

2.62

8.48

2.4

3.2

umol/l

37.7

41.0

0.53

152

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.34

8.45

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3102

34281

0.89

8.36

3.7

21.6

21.8

0.20

1187

14440

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

668

5274

1.28

8.25

2.0

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

268

1835

1.47

8.22

1.3

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

530

4068

1.31

8.13

1.2

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

114

2.99

8.01

2.0

2.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

910

10993

0.82

7.75

2.3

au/ml

26.5

22.4

0.21

734

(3000330) Specific gravity of Urine by Test strip

805

6568

1.24

7.51

4.2

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

718

5792

1.25

7.43

2.2

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

259

1803

1.44

7.34

5.5

6.7

mg/l

11.1

0.02

231

1658

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

+∞

7.29

1.4

0.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

1189

1.54

7.28

1.3

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

1189

1.54

7.28

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

1189

1.54

7.28

1.3

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

720

5833

1.24

7.18

1.5

1.8

g/l

1.7

1.5

5.34

612

4981

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

170

2597

0.65

7.16

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

304

2190

1.39

7.13

1.2

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

168

2567

0.65

7.09

1.2

1.3

ug/l

3.5

3.7

0.23

140

2330

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

876

0.41

7.07

1.4

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

189

1247

1.52

7.03

1.1

mg/l

287.4

284.8

0.19

170

1125

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

206

2.33

7.01

1.2

nmol/l

0.2

0.3

1.10

136

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

839

10109

0.82

6.98

1.2

1.3

au/ml

68.2

47.1

0.95

421

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

380

0.24

6.92

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1035

0.46

6.92

1.0

u/ml

0.3

1.1

—

142

(3033705) Calcium.ionized [Moles/volume] in Venous blood

212

1438

1.48

6.91

3.0

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

142

2.61

6.84

1.9

2.0

—

(3034770) Mitochondria Ab [Titer] in Serum

559

4427

1.27

6.81

1.2

1.3

titre

441.7

959.0

2.02

134

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1617

14162

1.15

6.79

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

134

827

1.62

6.67

1.5

1.7

nmol/l

1.4

1.2

1.47

105

653

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

216

1484

1.46

6.61

1.3

1.4

mmol/l

11.8

12.1

0.16

363

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3138

34227

0.90

6.52

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

539

1.77

6.47

2.5

2.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1115

0.50

6.45

1.1

1.0

u/ml

0.6

1.8

1.19

242

(40757373) Influenza virus identified in Isolate

280

2.07

6.40

1.5

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

346

2592

1.34

6.39

1.1

iu/ml

30666.7

807.7

0.48

624

(3051387) C reactive protein [Mass/volume] in Capillary blood

398

3045

1.31

6.36

4.9

3.2

mg/l

26.0

26.7

0.15

272

1880

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1025

0.49

6.29

1.1

iu/ml

17.3

7.9

0.76

270

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

559

1.74

6.27

1.2

2.3

ug/l

1.1

1.0

0.21

510

(3034092) Cytoplasmic Ig cells/100 cells in Blood

211

2.23

6.23

23.9

5.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

488

3848

1.28

6.20

1.5

1.9

iu/l

23.0

4.4

0.46

156

1471

(3045414) Leukocytes [Presence] in Urine

782

6495

1.21

6.19

2.1

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3402

31347

1.10

6.13

1.4

g/l

2.2

2.4

3.20

1835

20073

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

217

1516

1.44

6.12

1.3

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

429

5478

0.78

6.10

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1204

10404

1.17

6.07

1.9

2.5

g/l

66.2

66.8

2.16

1076

9529

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1491

0.59

5.88

1.5

1.6

mmol/l

8.0

7.7

0.37

907

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

256

2.07

5.87

3.0

2.1

mmol/l

7.1

7.6

0.36

150

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

294

3926

0.74

5.85

1.2

1.3

u/ml

4.8

5.5

0.16

411

(40758292) HTLV I+II Ab panel - Serum

304

0.23

5.81

1.3

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

804

1.58

5.76

1.1

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

661

5443

1.22

5.74

1.4

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

745

0.43

5.73

18.6

26.8

ug/l

108.8

116.0

0.16

611

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.34

5.70

1.3

1.7

u/l

0.4

0.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

301

3990

0.75

5.70

1.2

1.3

u/ml

8.2

8.3

0.01

639

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

216

1534

1.41

5.61

1.5

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

121

1878

0.64

5.60

1.4

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

420

3296

1.28

5.59

1.9

1.6

—

(4024509)

174

1197

1.46

5.39

1.8

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1047

0.53

5.37

1.4

nmol/l

17.6

31.8

6.13

956

(3009871) Measles virus Ab [Titer] in Serum

640

0.41

5.37

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3198

29563

1.10

5.34

1.8

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

301

1.93

5.31

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

140

2081

0.67

5.28

2.2

2.5

—

(3045424) Erythrocytes [Presence] in Urine

322

2462

1.31

5.25

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

634

7618

0.83

5.21

2.4

3.2

u/ml

41.1

45.9

0.31

600

7357

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

186

1308

1.43

5.14

2.5

2.9

—

(4281824)

1499

0.62

5.13

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

131

1952

0.67

5.03

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

574

1.64

5.00

3.1

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

343

2664

1.29

5.00

2.9

3.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

154

1056

1.46

4.89

2.0

1.9

u/field

3.1

1.8

1.17

484

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

153

2199

0.69

4.87

3.7

3.6

u/ml

37.0

35.4

0.09

147

2129

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

340

4331

0.78

4.83

1.2

1.3

u/ml

47.8

36.6

0.18

275

(40761539) Cells [Type] in Urine sediment by Light microscopy

342

1.82

4.75

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

755

1.54

4.75

1.9

1.7

u/field

1.7

2.9

1.53

555

(3006442) Creatine [Moles/volume] in Serum or Plasma

161

1126

1.43

4.63

1.7

1.5

umol/l

68.4

71.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

243

3208

0.75

4.56

1.2

1.3

u/ml

2.9

4.7

—

245

(4146454)

183

1315

1.40

4.53

2.5

2.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

100

638

1.57

4.49

1.1

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

292

2256

1.30

4.48

1.7

1.9

titre

1706.7

2969.2

0.88

122

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

548

0.42

4.46

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

800

1.50

4.43

1.4

1.5

—

(3042631) Mycobacterium sp identified in Specimen

226

1688

1.34

4.41

2.3

2.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

170

1213

1.41

4.40

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

278

0.29

4.33

1.0

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

242

3171

0.76

4.32

1.2

u/ml

44.5

18.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

663

0.48

4.30

2.1

2.0

mg/l

8.6

9.3

0.27

538

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1169

13178

0.88

4.30

3.0

4.1

ug/l

20.1

24.1

0.21

966

10463

(3045142) Bone marrow Pathology biopsy report

1469

0.65

4.27

1.2

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

146

1020

1.43

4.26

2.6

3.5

mu/l

39.1

28.1

1.28

125

964

(3003338) MCHC [Mass/volume]

13691

139530

0.93

4.24

34.0

15.0

g/l

332.2

333.4

42.60

13595

138466

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

254

1.89

4.23

1.1

1.5

ng/l

71.0

86.0

0.19

161

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

187

1374

1.36

4.09

1.3

1.9

—

(3000012) Reticulocyte production index

102

670

1.53

4.07

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

216

1.95

4.04

1.1

pmol/l

1.4

3.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

532

0.45

3.92

2.0

2.9

—

(3037121) Protein [Mass/volume] in Urine

568

4796

1.19

3.91

2.8

3.2

g/l

0.3

0.55

239

2169

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

364

1.71

3.91

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

909

10348

0.87

3.90

1.2

1.3

u/ml

301.9

260.6

0.33

804

9614

(3024471) HLA-A [Type]

598

0.48

3.89

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

232

1776

1.31

3.87

1.1

—

21.1

—

(4038314)

240

0.29

3.84

1.1

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

132

926

1.43

3.82

1.3

1.4

mmol/l

6.3

5.5

4.06

122

878

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

802

0.56

3.79

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

208

1.92

3.75

3.3

3.2

ml/dl

14.9

0.02

199

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

309

1.75

3.75

1.3

1.5

—

(3024932) HLA-DR beta [Type]

589

0.49

3.73

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2412

25969

0.92

3.70

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

518

1.57

3.68

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

717

0.54

3.67

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

106

719

1.48

3.67

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1116

0.63

3.64

1.1

1.0

u/ml

0.3

2.2

1.57

278

(40768795) Lymph node Pathology biopsy report

1441

0.68

3.64

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

106

724

1.47

3.56

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

157

2.04

3.54

2.0

2.4

mmol/l

0.8

1.0

0.29

105

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

360

1.67

3.53

1.4

1.3

nmol/l

107.9

122.9

0.35

279

(3008757) Leukocyte morphology finding [Identifier] in Blood

192

1452

1.33

3.53

2.8

3.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

261

3288

0.79

3.50

1.2

u/ml

50.7

42.0

0.26

328

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1141

0.65

3.49

1.9

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

380

4595

0.82

3.47

2.1

2.5

191.2

183.5

0.86

353

4364

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

1.98

3.47

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.98

3.40

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

1085

0.64

3.40

2.2

1.8

mg/l

3.2

3.7

0.63

1033

(3014051) Protein [Presence] in Urine by Test strip

382

3155

1.22

3.39

2.5

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1676

15357

1.10

3.38

2.8

4.4

u/l

227.2

239.5

3.10

1545

14553

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1094

0.65

3.36

1.0

—

(3042733) HLA Ab [Presence] in Serum

619

0.53

3.36

6.3

5.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.24

3.33

1.0

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

118

835

1.42

3.31

1.3

1.4

—

(40768793) Breast Pathology biopsy report

246

3096

0.79

3.29

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.92

3.29

1.1

1.0

pmol/l

126.5

129.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

947

8438

1.13

3.22

1.4

1.3

iu/l

21.2

26.1

5.54

736

7291

(3020961) Endomysium IgA Ab [Titer] in Serum

889

7891

1.13

3.21

1.1

titre

327.2

237.0

0.21

205

(3002619) Bacteria identified in Specimen by Culture

287

1.71

3.19

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

192

1479

1.30

3.14

1.7

2.0

ug/l

19.6

24.0

1.07

187

1448

(3022145) Colonoscopy Study observation

1553

16924

0.91

3.14

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

258

2064

1.25

3.12

1.4

1.6

mu/l

54.7

66.4

0.56

222

1867

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

216

1692

1.28

3.11

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

705

0.58

3.10

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

268

1.72

3.06

1.2

—

(3011648) Oxygen content in Venous blood

151

1129

1.34

3.06

1.7

2.5

11.5

11.2

0.31

151

1129

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1069

0.66

3.05

1.2

—

(40768443) Skin Pathology biopsy report

555

6417

0.86

3.04

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

392

1.58

3.02

1.1

—

(3034426) Prothrombin time (PT)

622

0.56

3.00

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

155

1168

1.33

2.99

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

530

0.53

2.98

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

3354

0.81

2.98

3.1

6.0

iu/ml

349.9

1549.9

1.46

493

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

853

1.39

2.97

1.3

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

149

1118

1.34

2.96

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

387

1.58

2.94

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

579

0.55

2.93

1.1

1.0

u/ml

4.9

9.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

224

0.36

2.90

2.3

2.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

278

3394

0.82

2.87

1.4

1.5

pmol/l

92.5

126.0

2.20

267

3306

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

799

0.62

2.85

2.9

3.1

mg/l

6.8

8.0

0.54

642

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

149

1126

1.33

2.84

1.1

—

(3020491) Glucose [Moles/volume] in Blood

151

1145

1.32

2.81

2.6

1.7

mmol/l

7.8

6.6

2.71

114

848

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

709

0.61

2.80

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

201

1.79

2.79

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

1594

1.27

2.79

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

394

1.55

2.75

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

396

4659

0.85

2.75

2.6

3.6

u/ml

984.7

1635.9

0.37

339

4008

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

294

3551

0.83

2.74

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

237

1911

1.24

2.73

1.3

1.4

pmol/l

430.4

309.1

1.65

182

1475

(3048929) Epstein Barr virus Ab [Presence] in Serum

518

5959

0.87

2.69

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1168

0.70

2.67

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

389

1.54

2.67

2.1

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

736

0.62

2.66

1.0

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1163

0.70

2.62

1.2

u/ml

34.3

40.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

155

1.87

2.60

3.3

2.4

u/field

0.4

0.7

1.02

155

(3004588) Protein electrophoresis panel - Serum or Plasma

937

8461

1.11

2.59

1.9

2.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

1017

0.69

2.56

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

330

2771

1.19

2.56

1.5

nmol/l

0.3

0.4

0.72

249

2196

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

107

2.06

2.56

1.6

1.2

ml/s/173m2

1.0

1.8

0.61

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

516

0.56

2.56

2.3

3.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

394

1.52

2.54

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

263

2168

1.22

2.49

1.2

1.3

u/l

28.5

32.1

0.23

227

1905

(21494815) CD4 cells/100 lymphocytes in Specimen

106

1429

0.74

2.49

2.2

40.9

41.6

—

200

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

418

4853

0.86

2.49

1.8

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

282

2343

1.21

2.47

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

430

1.49

2.45

1.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1158

0.72

2.43

1.8

2.7

e6/l

595.0

528.0

0.57

967

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1122

0.71

2.42

1.8

2.7

e9/l

0.2

0.67

964

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

211

1.71

2.41

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

221

0.41

2.41

1.6

1.7

mg/l

1.8

1.7

—

193

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

300

3565

0.84

2.39

1.4

u/ml

13.1

21.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

309

3662

0.84

2.39

1.2

—

(3001556) Androgen free Index in Serum or Plasma

235

1.66

2.37

1.7

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

2054

21861

0.93

2.37

1.3

1.4

titre

437.8

532.0

1.65

321

4276

(3001729) Color of Synovial fluid

111

1.98

2.34

1.4

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1207

0.73

2.34

2.1

2.8

e6/l

835.2

716.1

0.53

492

(3034860) Kappa light chains.free [Mass/volume] in Serum

436

3780

1.16

2.33

2.4

3.2

mg/l

54.2

67.6

0.34

351

3059

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

735

0.65

2.33

2.5

au/ml

256.3

137.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

2451

0.81

2.31

1.9

2.1

umol/l

6.4

6.6

0.05

146

1776

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

425

3680

1.16

2.31

2.4

3.2

ratio

1.3

2.5

1.94

314

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

112

1.97

2.29

1.7

4.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

217

0.41

2.29

1.0

—

(40768446) Kidney Pathology biopsy report

682

0.64

2.27

1.8

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

129

1665

0.77

2.25

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

302

1.56

2.23

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

313

0.48

2.23

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

434

3777

1.15

2.22

2.4

3.2

mg/l

37.6

46.0

0.98

348

3059

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

113

857

1.32

2.19

1.1

nmol/l

0.7

6.7

2.27

174

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

173

1.74

2.16

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

3.69

2.15

1.1

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

155

1943

0.80

2.14

1.2

1.3

u/ml

58.5

58.8

—

132

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

101

1.98

2.14

1.1

1.4

42.5

32.2

0.42

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

230

1905

1.21

2.13

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

462

0.58

2.12

2.1

e6/l

483.9

2540.8

0.64

317

(3018851) Theophylline [Moles/volume] in Serum or Plasma

102

1.96

2.09

1.6

1.7

umol/l

47.4

43.9

0.13

102

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

358

0.53

2.09

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

358

0.53

2.09

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

358

0.53

2.09

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

144

1136

1.27

2.09

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

190

1.69

2.09

1.2

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

131

1.83

2.07

1.0

1.1

—

(21494434) Karyotype in Bone marrow

1076

0.73

2.05

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

342

0.53

2.04

1.7

1.4

g/l

11.5

13.2

0.38

254

(3013166) Neutrophils/100 leukocytes in Synovial fluid

424

1.44

2.02

1.3

1.4

63.1

53.3

1.26

356

(3004716) Salmonella sp identified in Stool by Organism specific culture

963

8832

1.10

2.02

1.3

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1210

0.75

2.02

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

192

1.67

2.02

1.1

1.4

46.8

58.1

0.59

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.11

2.02

1.1

1.4

0.2

0.6

1.54

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

458

1.42

2.01

1.3

1.7

iu/ml

—

426.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

306

3568

0.86

2.00

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

252

2120

1.19

2.00

1.2

1.3

nmol/l

0.2

1.00

118

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1013

0.73

2.00

1.4

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.81

1.99

1.2

1.1

1.7

3.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

170

1.71

1.99

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

1144

1.26

1.99

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1207

0.75

1.99

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1207

0.75

1.99

1.2

—

(3048879) Bone marrow aspiration report

351

0.54

1.98

1.9

2.1

—

(40765096) Chromosome analysis panel by Banding

389

0.57

1.97

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

213

2553

0.83

1.94

2.0

2.8

u/ml

1084.6

3754.2

0.70

127

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

283

3310

0.85

1.94

1.4

1.5

u/ml

104.0

110.5

0.65

702

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

296

3449

0.86

1.93

1.2

1.3

u/ml

270.6

264.1

0.16

166

2277

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

522

1.38

1.91

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1198

0.76

1.90

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

359

0.56

1.90

1.1

1.3

—

(3011412) CD3 cells [#/volume] in Blood

123

1557

0.79

1.89

1.9

2.5

e9/l

1.3

1.2

0.85

910

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

251

2123

1.18

1.89

1.2

1.3

nmol/l

0.7

1.9

0.95

237

2051

(3023420) DNA double strand Ab [Units/volume] in Serum

142

1768

0.80

1.89

1.4

1.5

iu/ml

31.4

29.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1129

0.75

1.89

1.1

1.3

u/ml

2.2

1.3

0.30

495

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.96

1.89

1.1

1.5

10.9

12.4

0.09

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1197

0.76

1.89

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1195

0.76

1.87

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4165

43153

0.96

1.87

3.7

4.2

ug/l

2.5

2.6

0.09

3678

39258

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

591

6561

0.90

1.85

1.6

1.7

mg/l

4.0

3.5

1.09

481

4490

(3041918) Cholesterol [Moles/volume] in Pleural fluid

205

1.61

1.85

1.1

1.2

mmol/l

1.8

0.18

126

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

482

4286

1.13

1.84

2.0

1.9

pmol/l

179.4

204.3

5.47

445

4112

(3028717) Thiamine [Mass/volume] in Blood

167

1.68

1.83

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

130

1033

1.26

1.82

1.4

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

301

2595

1.16

1.81

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

101

1.88

1.80

1.3

1.2

—

(40768441) Liver Pathology biopsy report

1129

0.76

1.78

1.2

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

151

0.40

1.76

1.2

2.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

135

0.37

1.74

1.0

—

5.9

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

137

0.36

1.74

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

218

0.46

1.74

1.1

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

218

0.46

1.74

1.3

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

296

0.54

1.71

2.1

1.8

ug/l

1.9

3.2

0.71

168

(3003327) Ova and parasites identified in Stool by Light microscopy

628

5698

1.11

1.70

1.5

1.7

—

(3025577) Chromium [Mass/volume] in Blood

707

0.71

1.69

2.0

2.1

ug/l

2.2

2.5

0.25

592

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.69

0.0

2.4

—

23.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

407

0.61

1.68

2.2

1.9

e6/l

3940.9

15851.2

1.23

217

(4133840)

516

0.66

1.67

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

718

1.30

1.67

1.1

u/l

76.2

87.5

0.96

589

(40760888) Immunoglobulin light chains.free panel - Serum

329

2877

1.15

1.66

2.3

3.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

172

1.63

1.66

1.1

—

(3004775) Volume in Urine collected for unspecified duration

132

1065

1.24

1.65

1.9

2.4

734.1

678.9

0.66

760

(3046861) Legionella sp Ag [Presence] in Urine

2.10

1.65

1.4

1.0

—

(3033799) Differential panel - Peritoneal fluid

405

0.62

1.65

1.5

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

223

1895

1.18

1.64

1.3

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.97

1.64

1.1

u/l

32.0

50.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

694

1.30

1.63

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

954

0.75

1.62

5.9

6.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

269

1.49

1.62

2.1

2.7

mg/l

32.3

50.0

0.57

(3019832) Treponema pallidum Ab [Presence] in Serum

1927

20277

0.94

1.61

1.8

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

154

1862

0.83

1.60

1.2

1.1

98.3

96.4

0.39

140

1754

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

311

1.45

1.60

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.87

1.60

1.2

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.91

1.59

1.4

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

715

1.29

1.58

1.1

u/l

18.4

26.7

1.11

569

(3007461) Platelets [#/volume] in Blood

17828

177408

1.07

1.58

36.1

17.7

e9/l

257.0

253.5

10.21

17483

173226

(3019420) Tryptase [Mass/volume] in Serum or Plasma

880

0.75

1.57

1.5

ug/l

6.2

7.3

0.66

797

(3044007) Cell count panel - Peritoneal fluid

374

0.61

1.56

1.7

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

157

0.45

1.54

1.1

1.3

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

1.52

0.0

1.0

—

13.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

161

1.62

1.52

1.2

1.3

mmol/l

1.7

1.4

0.08

105

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

182

1533

1.19

1.51

1.1

1.2

u/l

58.0

62.6

0.43

126

1037

(3014891) Appearance of Pleural fluid

138

1.67

1.51

1.5

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

144

0.42

1.50

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

131

1070

1.23

1.50

1.2

1.3

mmol/l

6.0

6.3

0.46

114

987

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

160

1334

1.20

1.49

1.6

1.5

28.0

31.7

0.61

818

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.81

1.46

1.2

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

130

1066

1.22

1.44

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

244

1.48

1.44

3.9

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.73

1.42

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

454

5022

0.90

1.41

1.7

2.2

95.4

92.8

1.48

404

4665

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

226

2606

0.87

1.38

2.3

3.5

u/ml

155.4

801.5

1.77

199

2386

(3022493) Free Hemoglobin [Mass/volume] in Plasma

642

1.28

1.37

1.3

5.2

mg/l

70.0

2891.0

2.57

453

(3023199) Leukocytes [#/volume] in Pleural fluid

158

1328

1.19

1.37

1.4

1.5

e6/l

7522.3

2352.8

1.02

114

971

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

224

0.54

1.37

1.0

2.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

871

0.77

1.37

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

2078

19877

1.05

1.37

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

785

1.25

1.36

1.1

1.0

100.5

97.5

0.45

643

(3041184) Isoniazid [Presence] in Urine

2.94

1.36

1.8

2.6

—

(3010937) Rubella virus Ab [Presence] in Serum

124

0.40

1.35

1.0

1.1

—

(4268621)

156

1847

0.84

1.34

2.4

2.3

—

(3000060) B lymphocytes [#/volume] in Blood

478

0.69

1.34

1.5

2.1

e6/l

146.5

207.5

0.56

254

(3029612) Listeria sp Ab [Titer] in Serum

0.00

1.32

0.0

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

404

0.67

1.30

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

382

4242

0.90

1.30

1.9

2.1

mg/l

11.0

10.9

0.04

353

3977

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

412

1.34

1.28

1.3

1.4

56.7

60.8

0.39

343

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

122

1009

1.21

1.28

1.2

1.3

u/l

566.3

372.4

3.12

114

963

(3001893) Eosinophils/100 leukocytes in Pleural fluid

344

1.37

1.27

1.3

1.4

3.1

0.00

291

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

387

1.34

1.27

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.05

1.26

1.0

—

(3035880) pH of Pleural fluid

615

1.27

1.26

1.1

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

280

0.61

1.26

2.8

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

222

2542

0.87

1.26

1.1

1.2

—

(3004451) EKG impression Narrative

580

1.28

1.25

1.2

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

0.62

1.25

6.0

5.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

173

1484

1.17

1.22

1.3

1.5

g/l

35.3

33.5

1.30

157

1348

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

214

0.56

1.20

2.3

2.6

pmol/l

65.2

73.5

—

186

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

419

4606

0.91

1.20

2.0

2.7

g/l

3.7

3.6

1.12

393

4376

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

336

0.65

1.19

1.5

2.6

ng/l

108.4

109.0

—

166

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.31

1.18

1.0

—

(3017704) Immunofixation for Urine

630

1.26

1.18

1.2

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

133

1.58

1.17

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.3

—

107.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

102

1.67

1.16

1.8

1.4

—

(3024731) MCV [Entitic volume]

17831

177605

1.05

1.15

35.9

17.6

90.4

90.5

1.58

17597

175428

(3035941) MCH [Entitic mass]

17829

177585

1.05

1.15

35.8

17.6

30.1

30.2

22.93

17596

175409

(3047189) Immunofixation for 24 hour Urine

564

0.74

1.13

1.3

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

17831

177624

1.05

1.10

36.0

17.7

e12/l

4.6

1.18

17439

173040

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

371

1.32

1.10

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

233

2630

0.88

1.10

1.3

1.2

u/ml

3.4

3.9

0.33

105

1181

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

167

1444

1.16

1.09

1.1

1.2

mg/l

36.5

41.5

1.10

137

1216

(3010144) Erythrocytes [#/volume] in Synovial fluid

152

1305

1.17

1.09

1.3

1.4

e6/l

62088.6

94785.6

0.44

103

900

(36303858) Crystals [Presence] in Urine

2.38

1.09

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

157

1354

1.16

1.07

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

253

1.38

1.06

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

209

1842

1.14

1.05

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

209

1845

1.13

1.03

1.3

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

324

0.68

1.03

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

209

1847

1.13

1.02

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1139

0.83

1.01

2.1

—

(3010813) Leukocytes [#/volume] in Blood

17831

177667

1.05

1.00

36.4

17.7

e9/l

7.2

6.7

189.46

17436

173039

(3001964) Herpes simplex virus Ag [Presence] in Specimen

472

0.74

0.99

1.3

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

105

1245

0.84

0.99

1.8

2.1

73.7

0.01

1197

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

103

1223

0.84

0.99

1.8

2.1

11.5

14.2

1.74

591

(3033923) Metanephrine [Moles/time] in 24 hour Urine

300

1.33

0.98

1.1

umol/24h

0.7

0.9

0.36

145

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.80

0.98

1.0

u/ml

0.0

0.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

683

1.22

0.98

1.6

1.7

umol/l

2.0

0.02

635

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

167

1459

1.15

0.98

3.0

5.0

u/ml

33.0

92.4

3.57

478

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

175

0.57

0.97

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

435

0.74

0.96

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

858

1.19

0.96

1.1

1.2

u/l

17.6

21.5

0.43

733

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

105

886

1.19

0.96

1.1

1.2

u/l

81.5

88.0

0.42

773

(3000963) Hemoglobin [Mass/volume] in Blood

17831

177693

1.05

0.94

36.2

17.8

g/l

136.4

137.4

15.70

17601

175527

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

766

0.81

0.91

1.6

1.7

145.5

140.1

0.21

716

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

289

0.69

0.88

1.4

4.6

u/l

55.3

65.9

—

106

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

404

0.74

0.87

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

181

0.61

0.87

1.5

3.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.00

0.87

1.0

2.7

mu/l

0.9

2.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

229

0.65

0.86

1.7

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

561

0.78

0.86

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

426

0.75

0.86

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

276

0.69

0.86

1.0

1.3

—

101.5

—

(3000285) Sodium [Moles/volume] in Blood

161

1.43

0.86

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

906

1.17

0.86

1.4

1.6

u/l

4.7

5.7

0.22

456

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

780

0.82

0.85

1.1

u/ml

3.4

9.2

2.85

142

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

143

1629

0.88

0.84

2.6

3.3

nmol/l

6.1

9.5

0.44

133

1586

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

243

2683

0.90

0.84

1.3

1.2

u/ml

3.0

3.6

0.28

934

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

309

1.30

0.83

2.6

2.7

—

(3037756) Immunofixation for Serum or Plasma

274

2497

1.10

0.82

1.3

1.7

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

820

0.83

0.82

2.0

u/l

184.5

199.5

1.60

815

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

782

1.18

0.81

1.2

1.3

u/l

15.9

13.1

0.66

725

(3013247) Albumin in CSF/Albumin in Serum or Plasma

409

0.76

0.80

1.1

mg/g

5.2

7.1

2.21

386

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1315

13682

0.96

0.80

2.5

2.2

nmol/l

11.1

13.1

15.92

1121

12410

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

241

1.33

0.80

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

219

1978

1.11

0.79

3.2

3.0

nmol/l

0.8

0.05

168

1471

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

207

1.35

0.79

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

124

0.56

0.77

1.7

2.7

umol/l

174.0

359.5

—

117

(3006245) CD3-CD19+ cells/100 cells in Blood

650

0.81

0.77

1.5

2.1

14.0

9.5

1.23

611

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

358

1.26

0.76

1.2

1.3

39.7

38.2

0.10

238

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1238

11897

1.04

0.76

3.0

2.5

ml/min/173m2

70.2

0.02

493

4529

(4027681)

128

1123

1.14

0.76

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

148

1313

1.13

0.74

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

206

1863

1.11

0.74

1.3

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

658

0.82

0.74

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.64

0.73

1.1

nmol/l

189.2

258.6

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

134

0.60

0.73

1.0

3.0

—

46.7

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

108

0.56

0.72

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

858

1.15

0.71

1.5

u/ml

31.6

23.8

0.53

182

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

655

1.18

0.70

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

655

1.18

0.70

1.3

1.5

—

(3016750) Collection duration of Urine

785

1.16

0.70

1.8

2.3

min

521.4

499.7

1.15

614

(3036603) Volume of Urine

111

972

1.14

0.70

1.4

1.7

2330.0

1998.4

0.66

214

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

131

1161

1.13

0.69

1.3

1.4

umol/l

12.5

11.9

0.37

1116

(3028308) Erythrocytes [#/volume] in Pleural fluid

135

1199

1.13

0.69

1.4

1.5

e6/l

30676.6

49119.9

0.89

727

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

119

1348

0.88

0.69

1.3

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

117

1326

0.88

0.68

1.2

titre

59.2

198.6

5.12

228

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.54

0.66

5.4

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.54

0.66

2.4

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

231

2518

0.92

0.66

1.1

121.9

117.2

1.59

203

2296

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

853

0.86

0.66

8.8

6.6

u/ml

55.7

4026.6

0.64

192

(3017817) Protein [Mass] in Urine collected for unspecified duration

140

1252

1.12

0.65

2.7

—

0.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

260

2399

1.08

0.64

1.3

mmol/l

7.9

7.1

3.61

183

1765

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

204

1863

1.10

0.64

1.3

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

315

0.76

0.63

18.7

7.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

612

0.83

0.63

1.1

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

648

6803

0.95

0.63

2.1

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

177

1607

1.10

0.63

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

598

6291

0.95

0.63

1.3

miu/ml

202.7

224.9

0.63

164

2966

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

190

1732

1.10

0.62

1.1

1.2

—

(3024263) Appearance of Synovial fluid

748

1.15

0.62

1.4

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

127

1134

1.12

0.61

2.0

1.9

g/24h

0.7

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

544

0.83

0.61

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

489

0.82

0.60

1.1

1.5

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

163

0.67

0.59

1.0

u/ml

0.3

0.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

186

0.70

0.59

2.9

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

155

1405

1.10

0.58

1.0

1.1

mg/l

235.7

260.6

1.07

132

1247

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

123

1101

1.12

0.58

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

631

1.16

0.58

2.0

2.1

ug/min

127.1

133.7

0.03

144

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

916

0.87

0.57

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

241

2599

0.93

0.56

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

291

2716

1.07

0.56

2.0

2.3

titre

4.3

8.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

614

0.85

0.56

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

612

0.85

0.54

1.1

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

236

2190

1.08

0.54

1.3

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.46

0.54

1.2

1.6

ug/g

237.1

159.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

118

1060

1.11

0.54

1.2

1.1

ratio

1.1

0.71

372

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.48

0.53

7.0

11.3

—

(3051593) INR in Capillary blood by Coagulation assay

515

1.17

0.53

5.4

11.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

771

0.87

0.53

1.1

iu/ml

287.4

185.1

1.40

764

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.45

0.51

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

191

0.73

0.50

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

135

1229

1.10

0.49

3.3

3.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

206

2219

0.93

0.49

1.1

g/l

1.5

0.06

182

2020

(3035320) C reactive protein [Mass/volume] in Body fluid

120

1086

1.11

0.49

3.4

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1042

10096

1.03

0.49

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

112

1011

1.11

0.48

2.4

1.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.40

0.48

1.1

—

3.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

234

0.77

0.48

1.5

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

217

1.24

0.47

6.8

5.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

485

0.85

0.47

1.5

2.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

868

0.89

0.47

1.1

miu/ml

1781.0

1485.3

1.41

868

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

244

0.78

0.46

6.7

7.1

—

(3032057) Clostridioides difficile [Presence] in Stool

291

1.20

0.46

1.5

1.8

—

(3051651) Icteric interference index of Serum or Plasma

863

1.11

0.46

3.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

1150

0.90

0.46

1.4

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

221

0.77

0.46

1.1

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.62

0.45

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

354

3357

1.06

0.45

2.0

2.2

g/l

0.0

1.11

307

3060

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

243

0.78

0.45

4.0

5.2

ug/min

55.3

44.9

0.21

182

(3024869) Neuronal Ab [Presence] in Serum

255

1.22

0.45

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

276

0.80

0.45

1.5

2.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

843

0.89

0.44

1.2

1.1

u/ml

2.3

17.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

948

0.90

0.44

2.8

36.7

39.6

0.54

319

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

761

1.12

0.44

1.2

1.3

titre

1060.0

428.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.45

0.44

1.0

u/ml

0.0

0.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

121

1.32

0.44

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

693

0.88

0.43

3.8

3.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

423

4430

0.95

0.43

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

196

2100

0.93

0.43

2.7

3.1

u/ml

45.4

811.9

0.97

191

1984

(3030313) Adrenal Ab [Titer] in Serum

166

1.27

0.43

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

703

0.88

0.43

1.5

2.4

ug/l

19.2

207.1

1.26

674

(3044941) Cell count panel - Synovial fluid

232

2178

1.07

0.42

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

156

1684

0.93

0.42

1.2

1.4

g/l

0.4

0.21

106

1148

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

573

5956

0.96

0.42

1.6

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

149

1.28

0.41

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

3.6

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.41

0.0

2.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

204

1.23

0.40

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

561

0.87

0.40

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

314

0.83

0.39

1.3

mu/l

36.0

99.2

1.56

230

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

498

4786

1.04

0.39

1.1

u/ml

5.2

5.6

0.11

710

(3032868) Hemoglobin electrophoresis panel in Blood

171

0.76

0.39

1.5

—

(40768806) Pleura Pathology biopsy report

126

1161

1.09

0.39

1.4

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.39

0.0

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

466

4852

0.96

0.38

1.6

1.7

g/l

1.2

2.10

441

4633

(3027135) IgG subclass 1 [Mass/volume] in Serum

157

1685

0.93

0.38

1.2

1.4

g/l

6.6

6.8

0.23

105

1148

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.37

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

448

1.14

0.37

1.7

1.5

ug/l

10.8

8.6

1.85

448

(3028192) IgG subclass 2 [Mass/volume] in Serum

157

1683

0.93

0.37

1.2

1.4

g/l

2.8

3.0

0.34

107

1147

(3012565) Volume of 24 hour Urine

733

1.11

0.37

1.7

2.2

2261.8

2017.2

0.66

670

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

354

0.85

0.36

17.0

7.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

714

0.90

0.36

1.1

—

(3013762) Body weight Measured

1.27

0.36

1.2

1.1

—

(4306422)

249

2625

0.95

0.35

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

346

3309

1.05

0.35

2.1

2.2

g/l

0.0

0.00

306

3052

(3042951) Complement C1q Ab [Units/volume] in Serum

0.66

0.35

1.0

1.1

—

22.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

736

1.10

0.35

1.2

1.3

titre

28.0

84.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

2.3

2.6

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

0.4

1.9

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

1.0

0.8

—

100

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

1.3

2.3

0.55

106

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

0.8

1.8

—

103

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

3.3

4.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

2.3

0.01

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

0.6

1.7

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

144

1.25

0.35

1.7

1.6

mg/l

0.2

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.40

0.35

1.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

454

4715

0.96

0.35

1.6

1.7

g/l

0.2

0.65

428

4491

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

627

0.89

0.34

2.8

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

287

0.84

0.34

1.3

1.1

u/ml

1.2

1.8

0.27

200

(3025315) Body weight

133

0.75

0.33

6.2

4.1

—

(3035933) Granulocytes/100 leukocytes in Blood

467

0.88

0.33

15.2

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.30

0.33

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

692

1.10

0.32

1.6

1.5

2.5

3.7

0.65

163

(3009445) Proteinase 3 Ab [Units/volume] in Serum

653

6342

1.03

0.32

1.4

1.6

u/ml

22.9

13.2

0.58

194

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.31

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

528

0.89

0.31

1.2

1.1

104.8

91.5

1.52

244

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

174

1.21

0.31

1.2

1.4

7.7

12.0

0.43

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

197

0.81

0.31

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.32

0.30

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

965

0.92

0.30

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

299

2866

1.04

0.30

1.3

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

610

0.90

0.30

1.1

ng/l

226.3

420.5

0.43

140

(21494890) Protein electrophoresis panel - 24 hour Urine

135

1267

1.07

0.29

1.7

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

255

2666

0.96

0.29

1.3

1.6

g/l

0.6

0.8

1.57

187

1989

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

271

2829

0.96

0.29

1.2

titre

116.0

184.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

186

1.18

0.27

1.0

1.3

—

6.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

149

1.21

0.27

1.7

1.6

mg/l

2.5

2.1

—

101

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

173

1642

1.05

0.27

1.9

2.0

mg/l

26.5

25.6

0.06

423

(3016031) Almond IgE Ab [Units/volume] in Serum

104

1.25

0.26

1.0

u/ml

0.1

0.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1725

17000

1.02

0.26

4.8

4.0

29.5

31.8

15.76

1273

12033

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.68

0.26

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.67

0.25

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

250

2604

0.96

0.25

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

149

0.81

0.25

1.2

1.1

—

(44813793)

121

1139

1.06

0.25

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

609

6246

0.97

0.25

1.2

u/ml

0.3

1.0

4.11

549

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

192

0.83

0.25

1.1

1.0

u/ml

0.4

0.1

0.39

119

(4062490)

160

1684

0.95

0.25

1.2

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

428

4153

1.03

0.25

3.0

3.1

mg/l

1.5

1.4

0.84

386

3854

(44806071)

254

1.14

0.25

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.25

0.24

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

490

5035

0.97

0.24

1.6

titre

324.6

296.3

0.05

204

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

673

0.92

0.24

1.7

1.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.71

0.24

4.0

5.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

349

0.89

0.23

1.2

86.7

83.2

0.17

108

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

375

3637

1.03

0.23

2.0

2.2

g/l

0.0

2.83

327

3331

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.24

0.22

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

348

0.89

0.22

1.2

79.4

73.9

0.22

103

(4211845)

753

0.93

0.22

3.4

2.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

473

0.91

0.22

2.2

2.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.74

0.22

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.74

0.22

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

389

0.90

0.22

1.2

g/l

37.0

39.6

0.57

216

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

172

1.16

0.22

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.19

0.21

7.0

9.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

7.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.4

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

1.17

0.21

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

646

6593

0.98

0.20

1.7

2.0

u/l

38.2

39.5

0.92

569

5959

(3009992) Blasts/100 cells in Bone marrow

0.00

0.20

0.0

1.9

—

9.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

347

1.10

0.18

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

227

0.88

0.18

1.0

—

(3012441) Differential panel - Pleural fluid

120

1146

1.05

0.18

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

621

0.93

0.18

1.1

—

(3036489) Thrombin time

594

5829

1.02

0.17

1.7

2.1

20.2

21.3

4.26

494

5014

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

138

1.16

0.17

1.1

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

226

0.88

0.17

1.1

u/ml

0.0

0.3

—

144

(3011897) Casein IgE Ab [Units/volume] in Serum

272

1.10

0.17

1.1

u/ml

0.0

4.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

454

4446

1.02

0.16

2.0

2.2

g/l

10.0

10.3

0.67

362

3755

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.16

0.16

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

193

0.88

0.15

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

367

3752

0.98

0.15

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

750

1.05

0.15

1.3

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

750

1.05

0.15

1.3

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

750

1.05

0.15

1.3

2.1

—

(3044927) Protein electrophoresis panel - Urine

111

1158

0.96

0.15

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

307

0.91

0.15

1.4

1.6

ug/l

0.3

0.4

0.55

204

(3028026) IgM [Mass/volume] in Serum or Plasma

895

9066

0.99

0.14

1.5

1.9

g/l

1.3

0.09

801

8334

(3000475) Leukocytes [#/volume] in Synovial fluid

345

3376

1.02

0.14

1.5

1.6

e6/l

10836.3

13585.1

1.09

243

2476

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

333

1.08

0.14

1.2

pmol/l

424.0

322.8

0.42

244

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

583

0.94

0.14

1.4

2.4

—

(3020650) Glucose [Presence] in Urine

451

1.06

0.13

1.6

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

132

1.14

0.13

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

386

0.93

0.12

1.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

201

1.09

0.11

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

146

1419

1.03

0.11

3.6

3.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

126

0.87

0.11

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

136

0.88

0.11

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

134

1.12

0.10

6.1

3.1

g/mol

40.3

41.8

0.03

119

(3025130) Human papilloma virus identified in Specimen

223

2277

0.98

0.10

1.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

751

1.04

0.10

1.3

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

575

0.96

0.09

1.4

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

575

0.96

0.09

1.4

2.4

—

(3049242) von Willebrand panel - Platelet poor plasma

1.09

0.09

2.0

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.06

0.09

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.04

0.09

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.04

0.09

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

350

1.06

0.09

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

350

1.06

0.09

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

350

1.06

0.09

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

350

1.06

0.09

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

329

0.94

0.09

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

298

0.94

0.08

1.4

1.3

ug/l

36.2

272.0

1.72

162

(3028433) Virus identified in Specimen by Culture

518

1.04

0.08

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

144

0.90

0.08

1.0

1.1

umol/24h

2.1

1.8

0.57

144

(3025549) Creatine [Moles/time] in 24 hour Urine

123

0.89

0.08

1.2

1.4

—

14.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.83

0.07

1.0

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.83

0.07

1.0

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

4770

1.01

0.07

2.0

2.2

g/l

3.8

0.11

333

3436

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.84

0.07

2.9

3.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

153

0.91

0.07

2.7

3.2

mg/l

1.2

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

4773

1.01

0.07

2.0

2.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.03

0.07

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

559

0.97

0.06

1.1

—

(4015189)

346

0.95

0.06

2.3

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

145

1475

0.98

0.06

1.2

1.4

titre

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

4780

1.01

0.06

2.0

2.2

g/l

7.4

7.3

0.21

336

3604

(3042111) Morphology [Interpretation] in Bone marrow Narrative

209

2118

0.99

0.05

1.4

1.6

—

(3006270) Folate [Moles/volume] in Blood

117

1192

0.98

0.05

1.1

nmol/l

358.9

379.1

0.48

1040

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

583

1.03

0.05

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

929

0.98

0.05

1.2

1.5

u/l

5.5

6.0

0.79

804

(3012494) Peanut IgE Ab [Units/volume] in Serum

475

0.97

0.05

1.1

u/ml

4.7

2.5

0.33

256

(3003721) Smooth muscle Ab [Units/volume] in Serum

120

0.92

0.05

1.0

1.1

—

2.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

923

1.02

0.04

1.8

2.0

97.5

97.3

0.01

853

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

584

0.98

0.04

1.2

g/l

0.3

2.56

469

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

624

6208

1.01

0.04

1.9

1.8

nmol/l

37.7

38.9

0.63

605

6079

(3005719) IgG [Mass/volume] in Serum or Plasma

1168

11716

1.00

0.03

1.9

2.6

g/l

10.4

10.6

1.10

1035

10735

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

983

0.99

0.03

1.0

1.1

u/l

1.0

1.1

0.10

433

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

449

4511

1.00

0.03

1.9

2.2

g/l

3.1

3.0

0.32

333

3533

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

276

2777

0.99

0.02

1.3

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

132

1.06

0.02

1.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

425

4269

1.00

0.02

2.7

3.3

u/ml

0.4

0.3

0.72

256

2410

(3049717) Cytology report of Urine Cyto stain

450

4481

1.00

0.02

2.1

2.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

540

1.02

0.02

1.2

1.1

98.2

90.8

0.82

242

(3019174) dRVVT (LA screen)

168

0.95

0.02

1.3

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

401

1.02

0.02

1.7

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

107

0.93

0.02

1.2

1.4

umol/24h

306.8

326.5

—

107

(3050794) Legionella sp Ab [Presence] in Serum

123

1.06

0.01

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

370

3713

1.00

0.01

2.0

2.1

g/l

37.9

38.1

0.26

313

3215

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

257

0.97

0.01

4.8

6.1

60.9

69.8

0.85

200

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

563

1.01

0.01

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.06

0.01

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

166

0.96

0.00

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

177

1777

1.00

0.00

1.5

1.6

54.9

56.9

0.27

109

1121

(4212803)

114

0.96

0.00

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

115

0.96

0.00

1.2

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

238

1.01

0.00

1.3

—

90.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.02

0.00

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

210

1.00

0.00

10.7

10.4

mmol/l

5.1

5.4

0.35

210

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

405

4054

1.00

0.00

2.1

2.3

g/l

0.5

0.8

1.64

338

3517

(3022475) Manganese [Moles/volume] in Blood

107

1.03

0.00

1.1

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

261

1.00

0.00

1.0

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

949

1.00

0.00

1.1

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.95

0.00

1.0

1.1

11.2

8.3

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.95

0.00

1.0

1.1

22.2

20.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.97

0.00

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.92

0.00

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.3

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

2.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.91

0.00

18.1

9.8

e6/l

113.6

291.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.2

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

0.94

0.00

1.4

1.2

mmol/l

35.3

17.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_KELAMENT and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_KELAMENT	2.122 [1.96, 2.3]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.174

During the follow-up period (1.1.1998 — 31.12.2019), 8913 out of 42407 females with F5_KELAMENT died.

Males

Parameter	HR [95% CI]	p-value
F5_KELAMENT	2.646 [2.43, 2.88]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 8084 out of 39272 males with F5_KELAMENT died.

Mortality risk

Mortality risk for people of age

years, who have F5_KELAMENT.

N-year risk	Females	Males
1	0.239%	0.555%
5	1.198%	3.142%
10	2.811%	7.519%
15	5.192%	14.007%
20	9.173%	23.055%

Relationships between endpoints

↥

Index endpoint: F5_KELAMENT – Kela-code for severe mental illness

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Kela-code for severe mental illness

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints